data_2jqw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.644 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 20.6 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.73 47.48 2.58 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 113.185 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.644 ' HD3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.69 141.88 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.611 ' HB3' HD21 ' A' ' 14' ' ' LEU . 95.7 m -33.3 -62.66 0.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.038 . . . . 0.0 113.338 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.831 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -100.72 72.04 1.51 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.46 0.648 . . . . 0.0 110.047 173.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.606 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 3.5 ptp180 -64.98 -24.54 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.59 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 36.9 t80 -175.96 -50.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.758 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 60.2 Cg_endo -97.3 -26.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.741 1.628 . . . . 0.0 113.437 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.831 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 19.8 t30 64.98 31.78 11.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 110.109 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.86 -70.18 1.35 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.841 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.08 87.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.67 HD11 ' H ' ' A' ' 14' ' ' LEU . 1.9 mp -77.24 84.34 3.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 69.67 3.0 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.935 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.7 m . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.675 -178.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.41 104.38 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.912 2.408 . . . . 0.0 113.043 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.815 ' HZ2' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.68 168.01 15.66 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.9 m -41.75 -64.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.355 0.525 . . . . 0.0 111.519 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 9.0 p90 -95.25 86.03 4.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -67.14 -30.4 70.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 110.299 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 91.5 t80 -169.19 -51.87 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.683 173.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 93.8 Cg_endo -110.71 19.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 122.448 2.099 . . . . 0.0 112.366 173.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.7 p30 43.1 -107.77 0.1 Allowed 'General case' 0 C--N 1.347 0.5 0 O-C-N 123.496 0.498 . . . . 0.0 110.285 -171.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 67.49 -96.53 0.35 Allowed Glycine 0 C--N 1.307 -1.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.688 173.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 t -75.81 71.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.36 87.32 1.52 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.105 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.51 114.43 26.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 121.163 0.506 . . . . 0.0 110.312 -179.365 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 73.57 5.84 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.389 2.059 . . . . 0.0 111.462 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.482 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -64.45 147.13 53.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.533 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.1 m -51.15 136.62 23.64 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.778 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 3.9 p90 40.24 74.49 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.338 1.024 . . . . 0.0 110.659 -165.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -23.79 62.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 -172.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 37.6 t80 -173.06 -50.97 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.361 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 62.1 Cg_endo -111.38 16.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.839 2.359 . . . . 0.0 113.369 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.9 p30 41.08 -112.84 0.16 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 110.215 -166.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.43 -81.93 0.48 Allowed Glycine 0 C--N 1.309 -0.929 0 O-C-N 123.68 0.613 . . . . 0.0 112.459 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.15 87.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 14' ' ' LEU . 2.8 mp -87.47 63.91 7.9 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.17 90.8 4.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.198 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.99 178.75 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.5 94.02 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.207 2.604 . . . . 0.0 113.12 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.8 159.61 27.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.036 175.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.5 m -54.18 134.21 44.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.481 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.446 ' HA ' ' CA ' ' A' ' 11' ' ' ASN . 8.3 p90 40.35 61.57 1.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.092 0.87 . . . . 0.0 111.417 -170.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.91 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -64.74 -36.0 82.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.453 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.643 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.2 t80 -159.7 -53.26 0.01 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.375 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 84.6 Cg_endo -102.84 -15.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.191 1.927 . . . . 0.0 113.433 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.446 ' CA ' ' HA ' ' A' ' 7' ' ' PHE . 60.9 t30 69.58 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 14' ' ' LEU . . . 46.35 -109.66 0.39 Allowed Glycine 0 C--N 1.31 -0.87 0 O-C-N 124.828 1.33 . . . . 0.0 114.012 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 13' ' ' VAL . 5.0 p -79.21 86.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.913 0.863 . . . . 0.0 109.538 172.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.91 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.4 mp -64.1 117.37 7.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.817 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.73 25.88 9.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.165 -178.448 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.37 128.89 31.07 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.798 2.332 . . . . 0.0 113.353 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.525 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -107.22 154.98 20.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -39.36 -68.04 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.073 0.858 . . . . 0.0 111.741 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 11.3 p90 -91.6 92.25 8.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 168.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.728 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 5.4 ptp180 -83.92 -26.23 29.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.039 0.923 . . . . 0.0 109.535 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.573 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 74.3 t80 -176.86 -43.96 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.728 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 61.6 Cg_endo -98.54 157.63 0.74 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.183 1.922 . . . . 0.0 111.323 153.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.507 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 19.1 p30 -110.36 23.45 14.26 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 -82.73 0.16 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.031 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.85 69.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.41 71.74 1.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.576 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 108.19 17.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.809 -174.458 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 19.9 m . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 5.6 Cg_exo -69.8 103.79 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 111.594 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 3' ' ' SER . 12.3 mptt -59.4 150.84 25.25 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -43.1 -48.19 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.295 0.372 . . . . 0.0 111.052 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.2 p90 -114.47 79.11 1.22 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 167.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 1.045 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -69.92 -27.06 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.319 0.58 . . . . 0.0 109.945 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.534 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 39.4 t80 -168.7 -51.86 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.587 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.0 Cg_endo -104.19 -8.66 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.672 2.248 . . . . 0.0 114.096 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.844 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 44.47 45.91 7.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.416 0.686 . . . . 0.0 111.386 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.67 -82.71 1.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.178 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -94.87 90.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.045 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.3 mp -69.82 125.47 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.879 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.96 34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.465 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.491 -177.077 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.366 0.127 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.11 70.98 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.541 2.828 . . . . 0.0 113.496 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.19 162.18 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -51.89 133.42 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 4.8 p90 40.32 70.2 0.26 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.066 0.936 . . . . 0.0 111.074 -168.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.73 HH12 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -72.1 -31.25 65.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.046 -172.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 58.2 t80 -162.19 -43.63 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 19.0 Cg_endo -95.18 -80.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.234 1.956 . . . . 0.0 109.935 159.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 64.0 t30 151.02 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 11' ' ' ASN . . . 50.34 -122.36 12.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.149 168.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.89 88.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.656 0.741 . . . . 0.0 109.845 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.73 ' HA ' HH12 ' A' ' 8' ' ' ARG . 3.4 mp -67.66 133.53 49.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.481 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.28 23.53 14.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.739 0.78 . . . . 0.0 109.214 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.819 -175.044 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 91.8 Cg_exo -46.07 112.83 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.443 2.762 . . . . 0.0 114.041 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.13 113.01 18.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 175.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m 45.29 -90.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.21 -173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.583 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -86.05 85.7 7.36 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 176.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.57 ' HD3' ' HB3' ' A' ' 4' ' ' PRO . 2.9 ptp180 -77.52 -8.29 57.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.619 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 56.8 t80 179.68 -58.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.209 169.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 86.3 Cg_endo -105.41 -1.81 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.219 1.946 . . . . 0.0 114.029 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 7.8 p30 56.25 18.61 3.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.854 0.862 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 -71.9 1.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.421 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.63 100.45 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.512 0.672 . . . . 0.0 109.577 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.35 131.7 46.13 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.276 0.56 . . . . 0.0 111.525 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' H ' ' NH2' ' A' ' 8' ' ' ARG . . . -147.3 115.58 6.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.66 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.222 0.534 . . . . 0.0 109.955 -176.421 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.445 -0.681 0 CA-C-O 120.92 0.391 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.55 79.91 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.797 2.331 . . . . 0.0 112.5 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.61 151.89 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.379 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -58.03 137.37 56.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.791 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 4.6 p90 40.77 73.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.268 0.98 . . . . 0.0 110.857 -163.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.45 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 1.1 ptp180 -70.96 -19.31 62.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.891 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 65.9 t80 -172.29 -54.25 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.468 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.9 Cg_endo -99.63 -17.08 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.095 1.863 . . . . 0.0 113.759 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.791 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.1 OUTLIER 70.59 0.73 3.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.3 0.64 . . . . 0.0 111.535 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.88 -72.3 0.68 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.344 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -93.46 84.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.709 0.766 . . . . 0.0 109.854 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.45 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.6 75.65 7.46 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.37 0.605 . . . . 0.0 111.396 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.17 88.78 7.51 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.3 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.132 178.11 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 51.0 m . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 10.6 Cg_exo -67.98 99.8 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.2 1.933 . . . . 0.0 111.598 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -84.45 140.95 31.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.255 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -51.62 135.77 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.805 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.3 p90 38.29 74.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.08 0.862 . . . . 0.0 111.214 -165.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -18.82 61.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.397 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.516 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 7.1 t80 -175.25 -55.2 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.701 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 74.0 Cg_endo -103.4 -1.62 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.633 2.222 . . . . 0.0 114.206 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.918 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 41.79 36.22 0.6 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.37 0.668 . . . . 0.0 112.735 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 -53.43 3.98 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.867 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.68 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' H ' ' A' ' 14' ' ' LEU . 1.7 mp -82.54 71.09 9.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.166 0.508 . . . . 0.0 110.819 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.39 102.5 14.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.696 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' ARG . 60.9 Cg_endo -71.43 70.33 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.702 2.268 . . . . 0.0 113.667 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -69.86 159.17 34.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -58.56 138.32 56.88 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.342 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.542 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 5.9 p90 41.21 65.23 0.85 Allowed 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 124.093 0.871 . . . . 0.0 111.603 -168.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.796 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -73.91 -21.56 60.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.611 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 62.2 t80 -170.2 -53.94 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.449 173.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 70.0 Cg_endo -99.01 -25.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.777 1.651 . . . . 0.0 114.296 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 8.5 t30 63.94 36.6 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.95 0.881 . . . . 0.0 109.045 -173.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.25 -106.79 0.51 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.602 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.03 95.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.731 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.796 ' HA ' HH22 ' A' ' 8' ' ' ARG . 84.8 mt -83.24 109.49 17.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.993 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.04 32.09 6.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.559 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.792 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 36.5 Cg_endo -66.55 86.33 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.593 2.196 . . . . 0.0 112.082 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.77 155.38 31.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.94 -178.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.9 m -51.64 136.68 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.097 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 7.3 p90 39.41 68.74 0.34 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.0 -167.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -64.24 -25.79 68.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.854 -174.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.635 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 49.8 t80 -169.39 -52.58 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.668 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 53.4 Cg_endo -108.59 20.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.999 2.466 . . . . 0.0 113.023 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.81 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 8.3 p30 44.04 -105.41 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.818 0.699 . . . . 0.0 110.78 -171.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.525 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 68.23 -107.2 1.97 Allowed Glycine 0 C--N 1.302 -1.313 0 O-C-N 123.571 0.544 . . . . 0.0 112.36 172.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 13' ' ' VAL . 3.4 p -83.18 87.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD21 ' H ' ' A' ' 7' ' ' PHE . 4.9 mp -81.18 74.55 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.43 89.44 7.4 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.76 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.465 179.606 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.737 0.779 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -83.95 111.16 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.714 2.276 . . . . 0.0 113.191 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 9.7 mptt -79.98 144.38 33.33 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.558 ' O ' HD22 ' A' ' 14' ' ' LEU . 95.4 m -47.33 -56.3 7.12 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.272 0.358 . . . . 0.0 110.615 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 5.5 p90 -101.84 77.96 1.77 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.653 0.74 . . . . 0.0 109.079 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -60.66 -25.77 66.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.909 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 14.9 t80 -167.75 -57.45 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.256 168.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 45.4 Cg_endo -104.02 2.74 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.553 2.169 . . . . 0.0 113.432 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.793 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.5 p-10 47.26 28.71 1.07 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.819 0.848 . . . . 0.0 112.165 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.48 -66.36 1.56 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.415 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 13' ' ' VAL . 6.5 p -84.18 83.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.012 0.911 . . . . 0.0 109.408 174.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 6' ' ' CYS . 51.9 mt -76.5 81.23 3.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.951 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.11 93.12 4.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.5 p . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.59 . . . . 0.0 110.067 177.721 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.712 0.291 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 128.29 17.37 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.701 2.267 . . . . 0.0 113.116 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 1.5 mppt? -96.6 173.55 7.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 58.8 m -43.71 -61.12 1.51 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.557 0.617 . . . . 0.0 110.224 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.889 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 4.9 p90 -92.0 87.91 6.37 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.688 0.756 . . . . 0.0 109.132 167.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -71.8 -33.95 68.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.337 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.491 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 4.5 t80 -165.76 -51.37 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.738 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 69.6 Cg_endo -101.16 -7.55 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.238 1.959 . . . . 0.0 114.321 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.889 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.6 p-10 48.26 31.0 2.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.156 0.582 . . . . 0.0 111.541 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.72 -74.85 1.15 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.36 67.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.609 1.195 . . . . 0.0 109.921 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -93.92 151.41 19.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.149 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.66 26.26 5.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.014 -179.56 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.03 76.63 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.09 2.527 . . . . 0.0 112.674 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.424 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -56.36 148.57 18.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.108 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.96 139.76 57.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.803 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.658 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 13.8 p90 38.54 66.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.663 1.227 . . . . 0.0 110.691 -165.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.694 HH21 HD22 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -55.71 -27.15 48.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.796 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 67.8 t80 -168.06 -53.04 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.84 169.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 97.6 Cg_endo -103.48 -4.25 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.489 2.126 . . . . 0.0 113.895 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 1.9 p-10 49.84 19.13 0.4 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.795 . . . . 0.0 111.743 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -68.62 1.56 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.402 HG23 ' HD2' ' A' ' 8' ' ' ARG . 28.9 m -78.13 142.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.694 HD22 HH21 ' A' ' 8' ' ' ARG . 85.7 mt -136.96 101.82 4.68 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.03 53.78 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.239 0.543 . . . . 0.0 111.072 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.665 -179.709 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 12.9 m . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 3' ' ' SER . 3.5 Cg_exo -77.37 103.6 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.971 2.448 . . . . 0.0 111.882 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -84.58 155.58 22.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.864 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -57.4 134.35 55.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.755 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 8.2 p90 42.71 80.92 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.682 1.239 . . . . 0.0 110.986 -161.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.674 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.3 ptp180 -80.56 -88.82 0.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.559 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.542 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 17.2 t80 -100.29 -44.05 0.22 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 161.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.674 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 44.1 Cg_endo -104.28 144.85 0.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.787 2.325 . . . . 0.0 111.666 163.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.755 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 2.0 t-20 -90.18 13.77 14.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.607 1.194 . . . . 0.0 108.805 171.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.7 -84.12 0.3 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.613 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 94.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' CD2' ' H ' ' A' ' 7' ' ' PHE . 69.0 mt -100.7 89.3 3.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.847 -174.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.63 101.19 12.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.387 -177.459 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.171 0.51 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 152.24 53.83 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.969 2.446 . . . . 0.0 112.969 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -140.68 157.43 45.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.074 178.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.45 139.43 55.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 p90 43.08 70.41 0.3 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.233 1.016 . . . . 0.0 110.258 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -75.99 -18.19 59.4 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.907 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.54 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 11.3 t80 -165.16 -46.07 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.355 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 59.0 Cg_endo -101.06 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.49 2.126 . . . . 0.0 110.882 167.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.557 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 19.9 p-10 155.58 4.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.924 1.29 . . . . 0.0 108.09 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.6 -81.46 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.598 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.92 99.59 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.933 0.873 . . . . 0.0 109.919 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 11' ' ' ASN . 34.3 mt -92.3 75.02 5.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 95.76 10.3 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.841 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.146 178.791 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.3 p . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 7.4 Cg_exo -71.48 118.0 5.44 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.793 2.328 . . . . 0.0 112.136 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.6 153.56 29.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.682 -176.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.2 m -53.51 133.57 40.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 p90 43.47 75.89 0.09 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.342 1.068 . . . . 0.0 111.291 -162.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.506 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 2.3 ptp180 -76.29 -21.57 56.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.764 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.511 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 2.4 t80 -179.83 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 176.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 95.9 Cg_endo -102.82 -16.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.158 1.905 . . . . 0.0 113.255 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.446 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 t30 63.18 -149.46 0.34 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -171.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.0 -70.66 3.09 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.716 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -93.55 77.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.757 0.789 . . . . 0.0 109.407 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.01 91.05 6.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.713 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' H ' ' NH1' ' A' ' 8' ' ' ARG . . . -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.255 0.55 . . . . 0.0 110.141 170.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 p . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.153 178.017 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.649 0.261 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.561 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 24.4 Cg_endo -64.53 96.41 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.856 2.371 . . . . 0.0 112.394 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.572 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -81.99 169.97 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.382 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -55.86 135.83 51.79 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.661 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 12.7 p90 38.97 67.07 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.591 1.182 . . . . 0.0 110.854 -164.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.561 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -57.45 -26.37 61.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.822 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.549 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 35.3 t80 -171.9 -55.62 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.37 168.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 56.9 Cg_endo -99.9 -2.81 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.89 1.726 . . . . 0.0 114.397 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 9.3 p30 49.52 29.39 2.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.65 0.78 . . . . 0.0 112.478 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.15 -64.75 1.57 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.818 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 13' ' ' VAL . 6.0 p -88.89 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.328 1.061 . . . . 0.0 109.29 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.33 113.77 24.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.447 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.67 -58.43 1.83 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.851 175.463 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.565 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 73.6 Cg_endo -75.71 58.21 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.814 2.343 . . . . 0.0 112.408 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.72 153.32 43.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -58.2 150.25 22.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.822 -174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 18.5 p90 39.92 54.46 2.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.046 0.927 . . . . 0.0 110.999 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.507 HH12 ' HB1' ' A' ' 15' ' ' ALA . 3.0 ptp180 -59.9 -27.02 66.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.894 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.514 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.1 t80 -161.96 -54.36 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.8 167.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 83.0 Cg_endo -105.5 -8.32 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.017 1.811 . . . . 0.0 114.179 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 4.2 p30 53.0 15.77 0.63 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.498 0.719 . . . . 0.0 111.966 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.89 -62.66 2.92 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -83.74 137.48 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 169.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.59 158.78 39.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.944 0.402 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 4' ' ' PRO . . . -168.94 49.11 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.996 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.165 0.507 . . . . 0.0 111.997 -174.136 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.718 0.294 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.6 166.6 12.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.364 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.644 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 20.6 t -95.77 142.37 24.48 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.225 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.73 47.48 2.58 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 113.185 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.644 ' HD3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.69 141.88 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.611 ' HB3' HD21 ' A' ' 14' ' ' LEU . 95.7 m -33.3 -62.66 0.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.038 . . . . 0.0 113.338 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.831 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -100.72 72.04 1.51 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.46 0.648 . . . . 0.0 110.047 173.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.606 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 3.5 ptp180 -64.98 -24.54 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.59 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 36.9 t80 -175.96 -50.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.758 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 60.2 Cg_endo -97.3 -26.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.741 1.628 . . . . 0.0 113.437 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.831 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 19.8 t30 64.98 31.78 11.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 110.109 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.86 -70.18 1.35 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.841 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.08 87.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.67 HD11 ' H ' ' A' ' 14' ' ' LEU . 1.9 mp -77.24 84.34 3.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 69.67 3.0 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.935 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.7 m -112.01 -54.05 2.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.675 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.062 179.018 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.1 t80 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.816 0.341 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.73 121.53 20.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -150.56 108.02 3.12 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.594 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.41 104.38 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.912 2.408 . . . . 0.0 113.043 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.815 ' HZ2' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.68 168.01 15.66 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.9 m -41.75 -64.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.355 0.525 . . . . 0.0 111.519 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 9.0 p90 -95.25 86.03 4.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -67.14 -30.4 70.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 110.299 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 91.5 t80 -169.19 -51.87 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.683 173.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 93.8 Cg_endo -110.71 19.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 122.448 2.099 . . . . 0.0 112.366 173.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.7 p30 43.1 -107.77 0.1 Allowed 'General case' 0 C--N 1.347 0.5 0 O-C-N 123.496 0.498 . . . . 0.0 110.285 -171.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 67.49 -96.53 0.35 Allowed Glycine 0 C--N 1.307 -1.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.688 173.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 t -75.81 71.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.36 87.32 1.52 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.105 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.51 114.43 26.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 p -167.28 94.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.163 0.506 . . . . 0.0 110.312 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.396 179.317 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.17 0.509 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.8 147.75 26.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.1 p -107.44 136.92 19.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 73.57 5.84 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.389 2.059 . . . . 0.0 111.462 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -64.45 147.13 53.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.533 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.1 m -51.15 136.62 23.64 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.778 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 3.9 p90 40.24 74.49 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.338 1.024 . . . . 0.0 110.659 -165.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -23.79 62.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 -172.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 37.6 t80 -173.06 -50.97 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.361 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 62.1 Cg_endo -111.38 16.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.839 2.359 . . . . 0.0 113.369 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.9 p30 41.08 -112.84 0.16 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 110.215 -166.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.43 -81.93 0.48 Allowed Glycine 0 C--N 1.309 -0.929 0 O-C-N 123.68 0.613 . . . . 0.0 112.459 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.15 87.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 14' ' ' LEU . 2.8 mp -87.47 63.91 7.9 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.17 90.8 4.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.198 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 m -110.65 -33.6 6.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.99 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.504 179.228 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.839 0.352 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.05 114.51 4.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.18 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -84.87 132.4 46.16 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.921 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.5 94.02 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.207 2.604 . . . . 0.0 113.12 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.8 159.61 27.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.036 175.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.5 m -54.18 134.21 44.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.481 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.446 ' HA ' ' CA ' ' A' ' 11' ' ' ASN . 8.3 p90 40.35 61.57 1.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.092 0.87 . . . . 0.0 111.417 -170.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.91 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -64.74 -36.0 82.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.453 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.643 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.2 t80 -159.7 -53.26 0.01 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.375 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 84.6 Cg_endo -102.84 -15.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.191 1.927 . . . . 0.0 113.433 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.446 ' CA ' ' HA ' ' A' ' 7' ' ' PHE . 60.9 t30 69.58 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 14' ' ' LEU . . . 46.35 -109.66 0.39 Allowed Glycine 0 C--N 1.31 -0.87 0 O-C-N 124.828 1.33 . . . . 0.0 114.012 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 13' ' ' VAL . 5.0 p -79.21 86.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.913 0.863 . . . . 0.0 109.538 172.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.91 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.4 mp -64.1 117.37 7.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.817 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.73 25.88 9.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.68 138.94 31.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.165 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.357 -179.226 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.003 0.43 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.89 122.83 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.746 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -101.72 121.26 51.73 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.37 128.89 31.07 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.798 2.332 . . . . 0.0 113.353 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -107.22 154.98 20.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -39.36 -68.04 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.073 0.858 . . . . 0.0 111.741 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 11.3 p90 -91.6 92.25 8.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 168.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.728 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 5.4 ptp180 -83.92 -26.23 29.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.039 0.923 . . . . 0.0 109.535 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.573 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 74.3 t80 -176.86 -43.96 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.728 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 61.6 Cg_endo -98.54 157.63 0.74 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.183 1.922 . . . . 0.0 111.323 153.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.507 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 19.1 p30 -110.36 23.45 14.26 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 -82.73 0.16 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.031 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.85 69.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.41 71.74 1.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.576 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 108.19 17.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.417 ' C ' ' HG1' ' A' ' 17' ' ' THR . 1.8 m -109.81 -63.95 1.31 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.809 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 16' ' ' CYS . 36.5 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.731 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.29 125.73 28.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 111.334 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 19.9 m -109.36 140.65 22.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 176.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 5.6 Cg_exo -69.8 103.79 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 111.594 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 3' ' ' SER . 12.3 mptt -59.4 150.84 25.25 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -43.1 -48.19 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.295 0.372 . . . . 0.0 111.052 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.2 p90 -114.47 79.11 1.22 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 167.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.045 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -69.92 -27.06 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.319 0.58 . . . . 0.0 109.945 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.534 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 39.4 t80 -168.7 -51.86 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.587 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.0 Cg_endo -104.19 -8.66 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.672 2.248 . . . . 0.0 114.096 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.844 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 44.47 45.91 7.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.416 0.686 . . . . 0.0 111.386 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.67 -82.71 1.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.178 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -94.87 90.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.045 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.3 mp -69.82 125.47 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.879 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.96 34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.465 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -78.28 -68.83 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.491 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.437 179.808 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.63 144.44 46.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.835 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -74.19 139.49 75.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.039 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.11 70.98 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.541 2.828 . . . . 0.0 113.496 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.19 162.18 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -51.89 133.42 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 4.8 p90 40.32 70.2 0.26 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.066 0.936 . . . . 0.0 111.074 -168.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.73 HH12 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -72.1 -31.25 65.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.046 -172.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 58.2 t80 -162.19 -43.63 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 19.0 Cg_endo -95.18 -80.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.234 1.956 . . . . 0.0 109.935 159.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 64.0 t30 151.02 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 11' ' ' ASN . . . 50.34 -122.36 12.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.149 168.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.89 88.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.656 0.741 . . . . 0.0 109.845 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.73 ' HA ' HH12 ' A' ' 8' ' ' ARG . 3.4 mp -67.66 133.53 49.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.481 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.28 23.53 14.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.739 0.78 . . . . 0.0 109.214 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.3 p -116.38 136.8 52.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.819 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.006 177.15 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 61.4 t80 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.79 165.5 25.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.277 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -75.6 154.04 85.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.025 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 91.8 Cg_exo -46.07 112.83 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.443 2.762 . . . . 0.0 114.041 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.13 113.01 18.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 175.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m 45.29 -90.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.21 -173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.583 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -86.05 85.7 7.36 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 176.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.57 ' HD3' ' HB3' ' A' ' 4' ' ' PRO . 2.9 ptp180 -77.52 -8.29 57.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.619 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 56.8 t80 179.68 -58.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.209 169.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 86.3 Cg_endo -105.41 -1.81 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.219 1.946 . . . . 0.0 114.029 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 7.8 p30 56.25 18.61 3.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.854 0.862 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 -71.9 1.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.421 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.63 100.45 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.512 0.672 . . . . 0.0 109.577 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.35 131.7 46.13 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.276 0.56 . . . . 0.0 111.525 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' H ' ' NH2' ' A' ' 8' ' ' ARG . . . -147.3 115.58 6.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.66 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 m -138.11 -60.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.222 0.534 . . . . 0.0 109.955 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.869 177.578 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.25 125.78 20.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -78.82 120.04 79.45 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.765 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.55 79.91 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.797 2.331 . . . . 0.0 112.5 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.61 151.89 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.379 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -58.03 137.37 56.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.791 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 4.6 p90 40.77 73.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.268 0.98 . . . . 0.0 110.857 -163.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.45 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 1.1 ptp180 -70.96 -19.31 62.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.891 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 65.9 t80 -172.29 -54.25 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.468 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.9 Cg_endo -99.63 -17.08 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.095 1.863 . . . . 0.0 113.759 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.791 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.1 OUTLIER 70.59 0.73 3.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.3 0.64 . . . . 0.0 111.535 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.88 -72.3 0.68 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.344 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -93.46 84.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.709 0.766 . . . . 0.0 109.854 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.45 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.6 75.65 7.46 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.37 0.605 . . . . 0.0 111.396 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.17 88.78 7.51 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.3 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.58 19.46 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.501 -178.574 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 55.9 p90 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.82 147.26 46.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.704 0.287 . . . . 0.0 110.912 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 51.0 m -90.03 128.4 49.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.792 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 10.6 Cg_exo -67.98 99.8 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.2 1.933 . . . . 0.0 111.598 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -84.45 140.95 31.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.255 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -51.62 135.77 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.805 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.3 p90 38.29 74.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.08 0.862 . . . . 0.0 111.214 -165.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -18.82 61.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.397 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.516 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 7.1 t80 -175.25 -55.2 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.701 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 74.0 Cg_endo -103.4 -1.62 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.633 2.222 . . . . 0.0 114.206 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.918 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 41.79 36.22 0.6 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.37 0.668 . . . . 0.0 112.735 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 -53.43 3.98 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.867 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.68 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' H ' ' A' ' 14' ' ' LEU . 1.7 mp -82.54 71.09 9.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.166 0.508 . . . . 0.0 110.819 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.39 102.5 14.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 p -161.76 -39.66 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.7 m . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.111 176.342 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.79 164.74 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.359 0.6 . . . . 0.0 111.927 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -152.01 131.32 6.72 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.057 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' ARG . 60.9 Cg_endo -71.43 70.33 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.702 2.268 . . . . 0.0 113.667 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -69.86 159.17 34.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -58.56 138.32 56.88 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.342 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 5.9 p90 41.21 65.23 0.85 Allowed 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 124.093 0.871 . . . . 0.0 111.603 -168.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.796 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -73.91 -21.56 60.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.611 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 62.2 t80 -170.2 -53.94 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.449 173.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 70.0 Cg_endo -99.01 -25.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.777 1.651 . . . . 0.0 114.296 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 8.5 t30 63.94 36.6 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.95 0.881 . . . . 0.0 109.045 -173.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.25 -106.79 0.51 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.602 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.03 95.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.731 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.796 ' HA ' HH22 ' A' ' 8' ' ' ARG . 84.8 mt -83.24 109.49 17.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.993 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.04 32.09 6.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.559 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.83 130.32 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.792 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.463 -0.779 . . . . 0.0 109.84 178.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.71 154.9 18.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -98.04 138.12 20.92 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.729 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 36.5 Cg_endo -66.55 86.33 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.593 2.196 . . . . 0.0 112.082 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.77 155.38 31.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.94 -178.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.9 m -51.64 136.68 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.097 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 7.3 p90 39.41 68.74 0.34 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.0 -167.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -64.24 -25.79 68.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.854 -174.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.635 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 49.8 t80 -169.39 -52.58 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.668 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 53.4 Cg_endo -108.59 20.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.999 2.466 . . . . 0.0 113.023 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.81 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 8.3 p30 44.04 -105.41 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.818 0.699 . . . . 0.0 110.78 -171.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.525 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 68.23 -107.2 1.97 Allowed Glycine 0 C--N 1.302 -1.313 0 O-C-N 123.571 0.544 . . . . 0.0 112.36 172.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 13' ' ' VAL . 3.4 p -83.18 87.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD21 ' H ' ' A' ' 7' ' ' PHE . 4.9 mp -81.18 74.55 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.43 89.44 7.4 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.76 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p -140.25 16.15 2.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.465 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 C--O 1.247 0.972 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.9 179.525 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 53.2 p90 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.782 0.325 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.85 -2.51 15.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.456 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.8 m 63.66 141.57 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.737 0.779 . . . . 0.0 112.097 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -83.95 111.16 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.714 2.276 . . . . 0.0 113.191 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 9.7 mptt -79.98 144.38 33.33 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.558 ' O ' HD22 ' A' ' 14' ' ' LEU . 95.4 m -47.33 -56.3 7.12 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.272 0.358 . . . . 0.0 110.615 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 5.5 p90 -101.84 77.96 1.77 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.653 0.74 . . . . 0.0 109.079 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -60.66 -25.77 66.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.909 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 14.9 t80 -167.75 -57.45 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.256 168.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 45.4 Cg_endo -104.02 2.74 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.553 2.169 . . . . 0.0 113.432 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.793 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.5 p-10 47.26 28.71 1.07 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.819 0.848 . . . . 0.0 112.165 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.48 -66.36 1.56 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.415 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 13' ' ' VAL . 6.5 p -84.18 83.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.012 0.911 . . . . 0.0 109.408 174.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 6' ' ' CYS . 51.9 mt -76.5 81.23 3.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.951 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.11 93.12 4.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.5 p -140.3 7.61 2.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.59 . . . . 0.0 110.067 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.246 0.878 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.131 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 33.1 t80 . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.355 0.597 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.7 135.45 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.03 -0.419 . . . . 0.0 110.983 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p -67.99 140.2 93.49 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.52 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 128.29 17.37 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.701 2.267 . . . . 0.0 113.116 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 1.5 mppt? -96.6 173.55 7.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 58.8 m -43.71 -61.12 1.51 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.557 0.617 . . . . 0.0 110.224 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.889 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 4.9 p90 -92.0 87.91 6.37 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.688 0.756 . . . . 0.0 109.132 167.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -71.8 -33.95 68.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.337 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.491 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 4.5 t80 -165.76 -51.37 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.738 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 69.6 Cg_endo -101.16 -7.55 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.238 1.959 . . . . 0.0 114.321 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.889 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.6 p-10 48.26 31.0 2.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.156 0.582 . . . . 0.0 111.541 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.72 -74.85 1.15 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.36 67.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.609 1.195 . . . . 0.0 109.921 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -93.92 151.41 19.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.149 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.66 26.26 5.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p -94.15 -3.71 50.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.014 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.567 -178.767 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.87 128.82 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -81.35 138.78 48.26 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.6 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.03 76.63 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.09 2.527 . . . . 0.0 112.674 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.424 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -56.36 148.57 18.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.108 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.96 139.76 57.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.803 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 13.8 p90 38.54 66.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.663 1.227 . . . . 0.0 110.691 -165.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.694 HH21 HD22 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -55.71 -27.15 48.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.796 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 67.8 t80 -168.06 -53.04 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.84 169.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 97.6 Cg_endo -103.48 -4.25 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.489 2.126 . . . . 0.0 113.895 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 1.9 p-10 49.84 19.13 0.4 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.795 . . . . 0.0 111.743 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -68.62 1.56 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.402 HG23 ' HD2' ' A' ' 8' ' ' ARG . 28.9 m -78.13 142.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.694 HD22 HH21 ' A' ' 8' ' ' ARG . 85.7 mt -136.96 101.82 4.68 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.03 53.78 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.239 0.543 . . . . 0.0 111.072 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -146.69 -167.49 2.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.665 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.638 178.117 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.728 0.299 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.2 86.67 5.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.159 0.504 . . . . 0.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 12.9 m -82.96 128.23 66.34 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.384 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 3' ' ' SER . 3.5 Cg_exo -77.37 103.6 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.971 2.448 . . . . 0.0 111.882 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -84.58 155.58 22.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.864 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -57.4 134.35 55.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.755 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 8.2 p90 42.71 80.92 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.682 1.239 . . . . 0.0 110.986 -161.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.674 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.3 ptp180 -80.56 -88.82 0.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.559 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.542 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 17.2 t80 -100.29 -44.05 0.22 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 161.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.674 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 44.1 Cg_endo -104.28 144.85 0.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.787 2.325 . . . . 0.0 111.666 163.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.755 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 2.0 t-20 -90.18 13.77 14.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.607 1.194 . . . . 0.0 108.805 171.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.7 -84.12 0.3 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.613 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 94.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' CD2' ' H ' ' A' ' 7' ' ' PHE . 69.0 mt -100.7 89.3 3.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.847 -174.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.63 101.19 12.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.7 p -172.91 -27.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.387 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.3 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.197 178.421 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 120.287 0.089 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.73 -141.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.907 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t 72.25 116.68 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 123.591 0.756 . . . . 0.0 110.571 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 152.24 53.83 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.969 2.446 . . . . 0.0 112.969 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -140.68 157.43 45.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.074 178.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.45 139.43 55.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 p90 43.08 70.41 0.3 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.233 1.016 . . . . 0.0 110.258 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -75.99 -18.19 59.4 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.907 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.54 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 11.3 t80 -165.16 -46.07 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.355 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 59.0 Cg_endo -101.06 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.49 2.126 . . . . 0.0 110.882 167.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.557 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 19.9 p-10 155.58 4.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.924 1.29 . . . . 0.0 108.09 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.6 -81.46 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.598 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.92 99.59 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.933 0.873 . . . . 0.0 109.919 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 11' ' ' ASN . 34.3 mt -92.3 75.02 5.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 95.76 10.3 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.841 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.7 m -123.14 -38.38 2.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.146 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.246 0.901 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.169 -176.32 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.1 p90 . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.707 0.289 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.31 76.21 3.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.379 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.3 p -93.6 111.49 52.67 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.882 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 7.4 Cg_exo -71.48 118.0 5.44 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.793 2.328 . . . . 0.0 112.136 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.6 153.56 29.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.682 -176.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.2 m -53.51 133.57 40.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 p90 43.47 75.89 0.09 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.342 1.068 . . . . 0.0 111.291 -162.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.506 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 2.3 ptp180 -76.29 -21.57 56.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.764 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.511 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 2.4 t80 -179.83 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 176.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 95.9 Cg_endo -102.82 -16.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.158 1.905 . . . . 0.0 113.255 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.446 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 t30 63.18 -149.46 0.34 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -171.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.0 -70.66 3.09 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.716 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -93.55 77.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.757 0.789 . . . . 0.0 109.407 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.01 91.05 6.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.713 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' H ' ' NH1' ' A' ' 8' ' ' ARG . . . -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.255 0.55 . . . . 0.0 110.141 170.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 p -148.64 29.56 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.153 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.673 -177.449 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.877 0.37 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.49 100.58 10.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.912 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p -79.51 129.29 72.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.561 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 24.4 Cg_endo -64.53 96.41 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.856 2.371 . . . . 0.0 112.394 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.572 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -81.99 169.97 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.382 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -55.86 135.83 51.79 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.661 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 12.7 p90 38.97 67.07 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.591 1.182 . . . . 0.0 110.854 -164.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.561 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -57.45 -26.37 61.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.822 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.549 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 35.3 t80 -171.9 -55.62 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.37 168.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 56.9 Cg_endo -99.9 -2.81 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.89 1.726 . . . . 0.0 114.397 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 9.3 p30 49.52 29.39 2.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.65 0.78 . . . . 0.0 112.478 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.15 -64.75 1.57 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.818 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 13' ' ' VAL . 6.0 p -88.89 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.328 1.061 . . . . 0.0 109.29 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.33 113.77 24.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.447 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.67 -58.43 1.83 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.0 m 67.39 100.92 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.851 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.774 178.733 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 121.019 0.438 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.48 134.33 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.042 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -64.87 141.62 98.4 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 73.6 Cg_endo -75.71 58.21 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.814 2.343 . . . . 0.0 112.408 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.72 153.32 43.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -58.2 150.25 22.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.822 -174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 18.5 p90 39.92 54.46 2.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.046 0.927 . . . . 0.0 110.999 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.507 HH12 ' HB1' ' A' ' 15' ' ' ALA . 3.0 ptp180 -59.9 -27.02 66.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.894 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.514 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.1 t80 -161.96 -54.36 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.8 167.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 83.0 Cg_endo -105.5 -8.32 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.017 1.811 . . . . 0.0 114.179 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 4.2 p30 53.0 15.77 0.63 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.498 0.719 . . . . 0.0 111.966 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.89 -62.66 2.92 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -83.74 137.48 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 169.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.59 158.78 39.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.944 0.402 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 4' ' ' PRO . . . -168.94 49.11 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.996 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.5 p -143.06 86.12 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.165 0.507 . . . . 0.0 111.997 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.255 -0.879 . . . . 0.0 109.601 175.223 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.649 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 20.6 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.73 47.48 2.58 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 113.185 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.649 ' HD3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.69 141.88 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' HB3' HD23 ' A' ' 14' ' ' LEU . 95.7 m -33.3 -62.66 0.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.038 . . . . 0.0 113.338 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -100.72 72.04 1.51 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.46 0.648 . . . . 0.0 110.047 173.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.59 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 3.5 ptp180 -64.98 -24.54 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.59 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 36.9 t80 -175.96 -50.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.758 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 60.2 Cg_endo -97.3 -26.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.741 1.628 . . . . 0.0 113.437 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.849 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 19.8 t30 64.98 31.78 11.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 110.109 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.86 -70.18 1.35 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.841 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.08 87.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.9 mp -77.24 84.34 3.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 69.67 3.0 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.935 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.7 m . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.675 -178.938 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.41 104.38 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.912 2.408 . . . . 0.0 113.043 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.68 168.01 15.66 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.9 m -41.75 -64.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.355 0.525 . . . . 0.0 111.519 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 9.0 p90 -95.25 86.03 4.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -67.14 -30.4 70.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 110.299 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 91.5 t80 -169.19 -51.87 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.683 173.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 93.8 Cg_endo -110.71 19.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 122.448 2.099 . . . . 0.0 112.366 173.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.7 p30 43.1 -107.77 0.1 Allowed 'General case' 0 C--N 1.347 0.5 0 O-C-N 123.496 0.498 . . . . 0.0 110.285 -171.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.49 -96.53 0.35 Allowed Glycine 0 C--N 1.307 -1.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.688 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 t -75.81 71.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.36 87.32 1.52 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.105 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.51 114.43 26.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 121.163 0.506 . . . . 0.0 110.312 -179.365 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 73.57 5.84 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.389 2.059 . . . . 0.0 111.462 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.566 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -64.45 147.13 53.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.533 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.1 m -51.15 136.62 23.64 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 3.9 p90 40.24 74.49 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.338 1.024 . . . . 0.0 110.659 -165.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.72 -23.79 62.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 -172.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 37.6 t80 -173.06 -50.97 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.361 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 62.1 Cg_endo -111.38 16.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.839 2.359 . . . . 0.0 113.369 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.821 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.9 p30 41.08 -112.84 0.16 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 110.215 -166.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.43 -81.93 0.48 Allowed Glycine 0 C--N 1.309 -0.929 0 O-C-N 123.68 0.613 . . . . 0.0 112.459 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.15 87.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 14' ' ' LEU . 2.8 mp -87.47 63.91 7.9 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.17 90.8 4.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.198 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.99 178.75 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.5 94.02 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.207 2.604 . . . . 0.0 113.12 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.612 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.8 159.61 27.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.036 175.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.5 m -54.18 134.21 44.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.481 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.451 ' HA ' ' CA ' ' A' ' 11' ' ' ASN . 8.3 p90 40.35 61.57 1.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.092 0.87 . . . . 0.0 111.417 -170.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.927 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -64.74 -36.0 82.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.453 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.676 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.2 t80 -159.7 -53.26 0.01 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.375 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 84.6 Cg_endo -102.84 -15.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.191 1.927 . . . . 0.0 113.433 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CA ' ' HA ' ' A' ' 7' ' ' PHE . 60.9 t30 69.58 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.491 ' O ' HD12 ' A' ' 14' ' ' LEU . . . 46.35 -109.66 0.39 Allowed Glycine 0 C--N 1.31 -0.87 0 O-C-N 124.828 1.33 . . . . 0.0 114.012 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.21 86.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.913 0.863 . . . . 0.0 109.538 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.927 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.4 mp -64.1 117.37 7.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.817 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.73 25.88 9.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.165 -178.448 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.37 128.89 31.07 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.798 2.332 . . . . 0.0 113.353 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.56 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -107.22 154.98 20.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -39.36 -68.04 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.073 0.858 . . . . 0.0 111.741 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 11.3 p90 -91.6 92.25 8.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 168.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.751 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 5.4 ptp180 -83.92 -26.23 29.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.039 0.923 . . . . 0.0 109.535 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.618 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 74.3 t80 -176.86 -43.96 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.751 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 61.6 Cg_endo -98.54 157.63 0.74 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.183 1.922 . . . . 0.0 111.323 153.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.508 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 19.1 p30 -110.36 23.45 14.26 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 -82.73 0.16 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.031 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.85 69.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.594 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.41 71.74 1.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.576 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' N ' HH22 ' A' ' 8' ' ' ARG . . . -84.76 108.19 17.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.809 -174.458 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 19.9 m . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 5.6 Cg_exo -69.8 103.79 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 111.594 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 12.3 mptt -59.4 150.84 25.25 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -43.1 -48.19 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.295 0.372 . . . . 0.0 111.052 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.863 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.2 p90 -114.47 79.11 1.22 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 167.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 1.047 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -69.92 -27.06 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.319 0.58 . . . . 0.0 109.945 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 39.4 t80 -168.7 -51.86 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.587 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.0 Cg_endo -104.19 -8.66 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.672 2.248 . . . . 0.0 114.096 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.863 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 44.47 45.91 7.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.416 0.686 . . . . 0.0 111.386 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.67 -82.71 1.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.178 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -94.87 90.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.047 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.3 mp -69.82 125.47 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.879 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.96 34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.465 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.491 -177.077 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.366 0.127 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.11 70.98 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.541 2.828 . . . . 0.0 113.496 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.19 162.18 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -51.89 133.42 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 4.8 p90 40.32 70.2 0.26 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.066 0.936 . . . . 0.0 111.074 -168.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.766 HH12 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -72.1 -31.25 65.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.046 -172.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.62 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 58.2 t80 -162.19 -43.63 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 19.0 Cg_endo -95.18 -80.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.234 1.956 . . . . 0.0 109.935 159.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 64.0 t30 151.02 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 11' ' ' ASN . . . 50.34 -122.36 12.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.149 168.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.89 88.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.656 0.741 . . . . 0.0 109.845 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.766 ' HA ' HH12 ' A' ' 8' ' ' ARG . 3.4 mp -67.66 133.53 49.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.481 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.28 23.53 14.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.739 0.78 . . . . 0.0 109.214 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 14' ' ' LEU . 25.3 p . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.819 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 91.8 Cg_exo -46.07 112.83 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.443 2.762 . . . . 0.0 114.041 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.5 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.13 113.01 18.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 175.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' HD23 ' A' ' 14' ' ' LEU . 86.3 m 45.29 -90.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.21 -173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -86.05 85.7 7.36 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 176.588 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' NH2' ' H ' ' A' ' 15' ' ' ALA . 2.9 ptp180 -77.52 -8.29 57.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 56.8 t80 179.68 -58.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.209 169.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 86.3 Cg_endo -105.41 -1.81 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.219 1.946 . . . . 0.0 114.029 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 7.8 p30 56.25 18.61 3.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.854 0.862 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 -71.9 1.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.421 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 8' ' ' ARG . 2.9 p -74.63 100.45 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.512 0.672 . . . . 0.0 109.577 172.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 6' ' ' CYS . 72.9 mt -100.35 131.7 46.13 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.276 0.56 . . . . 0.0 111.525 -174.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.593 ' H ' ' NH2' ' A' ' 8' ' ' ARG . . . -147.3 115.58 6.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.66 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.222 0.534 . . . . 0.0 109.955 -176.421 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.445 -0.681 0 CA-C-O 120.92 0.391 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.55 79.91 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.797 2.331 . . . . 0.0 112.5 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.61 151.89 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.379 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -58.03 137.37 56.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.822 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 4.6 p90 40.77 73.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.268 0.98 . . . . 0.0 110.857 -163.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 1.1 ptp180 -70.96 -19.31 62.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.891 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 65.9 t80 -172.29 -54.25 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.468 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.9 Cg_endo -99.63 -17.08 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.095 1.863 . . . . 0.0 113.759 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 70.59 0.73 3.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.3 0.64 . . . . 0.0 111.535 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.88 -72.3 0.68 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.344 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -93.46 84.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.709 0.766 . . . . 0.0 109.854 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.6 75.65 7.46 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.37 0.605 . . . . 0.0 111.396 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.17 88.78 7.51 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.3 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.132 178.11 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 51.0 m . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 10.6 Cg_exo -67.98 99.8 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.2 1.933 . . . . 0.0 111.598 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.593 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -84.45 140.95 31.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.255 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -51.62 135.77 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.805 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.3 p90 38.29 74.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.08 0.862 . . . . 0.0 111.214 -165.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -18.82 61.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.397 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 7.1 t80 -175.25 -55.2 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.701 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 74.0 Cg_endo -103.4 -1.62 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.633 2.222 . . . . 0.0 114.206 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 41.79 36.22 0.6 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.37 0.668 . . . . 0.0 112.735 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 -53.43 3.98 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.867 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.68 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.69 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp -82.54 71.09 9.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.166 0.508 . . . . 0.0 110.819 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.39 102.5 14.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.696 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' ARG . 60.9 Cg_endo -71.43 70.33 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.702 2.268 . . . . 0.0 113.667 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.526 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -69.86 159.17 34.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -58.56 138.32 56.88 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.342 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 5.9 p90 41.21 65.23 0.85 Allowed 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 124.093 0.871 . . . . 0.0 111.603 -168.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.817 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -73.91 -21.56 60.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.648 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 62.2 t80 -170.2 -53.94 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.449 173.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 70.0 Cg_endo -99.01 -25.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.777 1.651 . . . . 0.0 114.296 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 8.5 t30 63.94 36.6 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.95 0.881 . . . . 0.0 109.045 -173.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.25 -106.79 0.51 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.602 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.03 95.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.731 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.817 ' HA ' HH22 ' A' ' 8' ' ' ARG . 84.8 mt -83.24 109.49 17.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.993 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.04 32.09 6.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.559 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.792 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 36.5 Cg_endo -66.55 86.33 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.593 2.196 . . . . 0.0 112.082 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.77 155.38 31.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.94 -178.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.9 m -51.64 136.68 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.097 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.826 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 7.3 p90 39.41 68.74 0.34 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.0 -167.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.546 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -64.24 -25.79 68.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.854 -174.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 49.8 t80 -169.39 -52.58 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.668 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 53.4 Cg_endo -108.59 20.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.999 2.466 . . . . 0.0 113.023 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.826 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 8.3 p30 44.04 -105.41 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.818 0.699 . . . . 0.0 110.78 -171.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 68.23 -107.2 1.97 Allowed Glycine 0 C--N 1.302 -1.313 0 O-C-N 123.571 0.544 . . . . 0.0 112.36 172.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 13' ' ' VAL . 3.4 p -83.18 87.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 7' ' ' PHE . 4.9 mp -81.18 74.55 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.43 89.44 7.4 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.76 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.465 179.606 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.737 0.779 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -83.95 111.16 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.714 2.276 . . . . 0.0 113.191 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 9.7 mptt -79.98 144.38 33.33 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.56 ' O ' HD23 ' A' ' 14' ' ' LEU . 95.4 m -47.33 -56.3 7.12 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.272 0.358 . . . . 0.0 110.615 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.827 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 5.5 p90 -101.84 77.96 1.77 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.653 0.74 . . . . 0.0 109.079 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -60.66 -25.77 66.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.909 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.594 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 14.9 t80 -167.75 -57.45 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.256 168.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 45.4 Cg_endo -104.02 2.74 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.553 2.169 . . . . 0.0 113.432 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.827 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.5 p-10 47.26 28.71 1.07 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.819 0.848 . . . . 0.0 112.165 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.48 -66.36 1.56 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.415 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.5 p -84.18 83.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.012 0.911 . . . . 0.0 109.408 174.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 6' ' ' CYS . 51.9 mt -76.5 81.23 3.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.951 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.11 93.12 4.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.5 p . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.59 . . . . 0.0 110.067 177.721 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.712 0.291 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 128.29 17.37 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.701 2.267 . . . . 0.0 113.116 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 1.5 mppt? -96.6 173.55 7.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 58.8 m -43.71 -61.12 1.51 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.557 0.617 . . . . 0.0 110.224 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.923 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 4.9 p90 -92.0 87.91 6.37 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.688 0.756 . . . . 0.0 109.132 167.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.5 ptp180 -71.8 -33.95 68.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.337 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 4.5 t80 -165.76 -51.37 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.738 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 69.6 Cg_endo -101.16 -7.55 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.238 1.959 . . . . 0.0 114.321 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.6 p-10 48.26 31.0 2.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.156 0.582 . . . . 0.0 111.541 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.72 -74.85 1.15 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.36 67.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.609 1.195 . . . . 0.0 109.921 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -93.92 151.41 19.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.149 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.66 26.26 5.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.014 -179.56 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.03 76.63 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.09 2.527 . . . . 0.0 112.674 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -56.36 148.57 18.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.108 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.96 139.76 57.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.803 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.681 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 13.8 p90 38.54 66.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.663 1.227 . . . . 0.0 110.691 -165.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.701 HH21 HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -55.71 -27.15 48.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.796 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 67.8 t80 -168.06 -53.04 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.84 169.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 97.6 Cg_endo -103.48 -4.25 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.489 2.126 . . . . 0.0 113.895 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.681 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 1.9 p-10 49.84 19.13 0.4 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.795 . . . . 0.0 111.743 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -68.62 1.56 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 8' ' ' ARG . 28.9 m -78.13 142.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 HH21 ' A' ' 8' ' ' ARG . 85.7 mt -136.96 101.82 4.68 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.03 53.78 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.239 0.543 . . . . 0.0 111.072 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.665 -179.709 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 12.9 m . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 3' ' ' SER . 3.5 Cg_exo -77.37 103.6 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.971 2.448 . . . . 0.0 111.882 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -84.58 155.58 22.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.864 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -57.4 134.35 55.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.766 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 8.2 p90 42.71 80.92 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.682 1.239 . . . . 0.0 110.986 -161.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.3 ptp180 -80.56 -88.82 0.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.559 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.565 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 17.2 t80 -100.29 -44.05 0.22 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 161.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.701 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 44.1 Cg_endo -104.28 144.85 0.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.787 2.325 . . . . 0.0 111.666 163.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 1.2 t30 -90.18 13.77 14.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.607 1.194 . . . . 0.0 108.805 171.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.7 -84.12 0.3 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.613 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 94.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 11' ' ' ASN . 69.0 mt -100.7 89.3 3.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.847 -174.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.63 101.19 12.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.387 -177.459 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.171 0.51 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 152.24 53.83 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.969 2.446 . . . . 0.0 112.969 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -140.68 157.43 45.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.074 178.624 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.45 139.43 55.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 19.2 p90 43.08 70.41 0.3 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.233 1.016 . . . . 0.0 110.258 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -75.99 -18.19 59.4 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.907 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 11.3 t80 -165.16 -46.07 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.355 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 59.0 Cg_endo -101.06 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.49 2.126 . . . . 0.0 110.882 167.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 19.9 p-10 155.58 4.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.924 1.29 . . . . 0.0 108.09 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' H ' ' H ' ' A' ' 11' ' ' ASN . . . -58.6 -81.46 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.598 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.92 99.59 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.933 0.873 . . . . 0.0 109.919 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 11' ' ' ASN . 34.3 mt -92.3 75.02 5.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 95.76 10.3 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.841 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.146 178.791 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.3 p . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.53 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 7.4 Cg_exo -71.48 118.0 5.44 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.793 2.328 . . . . 0.0 112.136 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.6 153.56 29.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.682 -176.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.2 m -53.51 133.57 40.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 p90 43.47 75.89 0.09 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.342 1.068 . . . . 0.0 111.291 -162.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.575 HH12 ' H ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -76.29 -21.57 56.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.764 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 2.4 t80 -179.83 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 95.9 Cg_endo -102.82 -16.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.158 1.905 . . . . 0.0 113.255 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.412 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 t30 63.18 -149.46 0.34 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -171.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.0 -70.66 3.09 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.716 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -93.55 77.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.757 0.789 . . . . 0.0 109.407 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.01 91.05 6.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.713 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.575 ' H ' HH12 ' A' ' 8' ' ' ARG . . . -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.255 0.55 . . . . 0.0 110.141 170.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 p . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.153 178.017 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.649 0.261 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 24.4 Cg_endo -64.53 96.41 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.856 2.371 . . . . 0.0 112.394 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -81.99 169.97 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.382 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -55.86 135.83 51.79 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 12.7 p90 38.97 67.07 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.591 1.182 . . . . 0.0 110.854 -164.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.575 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -57.45 -26.37 61.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.822 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 35.3 t80 -171.9 -55.62 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.37 168.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 56.9 Cg_endo -99.9 -2.81 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.89 1.726 . . . . 0.0 114.397 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 9.3 p30 49.52 29.39 2.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.65 0.78 . . . . 0.0 112.478 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.15 -64.75 1.57 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.818 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.0 p -88.89 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.328 1.061 . . . . 0.0 109.29 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.33 113.77 24.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.447 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.67 -58.43 1.83 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.851 175.463 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 73.6 Cg_endo -75.71 58.21 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.814 2.343 . . . . 0.0 112.408 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.72 153.32 43.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -58.2 150.25 22.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.822 -174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 18.5 p90 39.92 54.46 2.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.046 0.927 . . . . 0.0 110.999 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.516 HH12 ' HB3' ' A' ' 15' ' ' ALA . 3.0 ptp180 -59.9 -27.02 66.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.894 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.1 t80 -161.96 -54.36 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.8 167.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 83.0 Cg_endo -105.5 -8.32 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.017 1.811 . . . . 0.0 114.179 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 4.2 p30 53.0 15.77 0.63 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.498 0.719 . . . . 0.0 111.966 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.89 -62.66 2.92 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -83.74 137.48 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 169.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.59 158.78 39.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.944 0.402 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -168.94 49.11 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.996 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.165 0.507 . . . . 0.0 111.997 -174.136 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.718 0.294 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.6 166.6 12.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.364 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.649 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 20.6 t -95.77 142.37 24.48 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.225 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.73 47.48 2.58 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 113.185 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.649 ' HD3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.69 141.88 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' HB3' HD23 ' A' ' 14' ' ' LEU . 95.7 m -33.3 -62.66 0.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.038 . . . . 0.0 113.338 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -100.72 72.04 1.51 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.46 0.648 . . . . 0.0 110.047 173.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.59 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 3.5 ptp180 -64.98 -24.54 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.59 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 36.9 t80 -175.96 -50.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.758 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 60.2 Cg_endo -97.3 -26.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.741 1.628 . . . . 0.0 113.437 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.849 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 19.8 t30 64.98 31.78 11.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 110.109 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.86 -70.18 1.35 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.841 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.08 87.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.9 mp -77.24 84.34 3.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 69.67 3.0 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.935 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.7 m -112.01 -54.05 2.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.675 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.062 179.018 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.1 t80 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.816 0.341 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.73 121.53 20.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -150.56 108.02 3.12 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.594 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.41 104.38 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.912 2.408 . . . . 0.0 113.043 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.68 168.01 15.66 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.9 m -41.75 -64.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.355 0.525 . . . . 0.0 111.519 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 9.0 p90 -95.25 86.03 4.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -67.14 -30.4 70.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 110.299 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 91.5 t80 -169.19 -51.87 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.683 173.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 93.8 Cg_endo -110.71 19.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 122.448 2.099 . . . . 0.0 112.366 173.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.7 p30 43.1 -107.77 0.1 Allowed 'General case' 0 C--N 1.347 0.5 0 O-C-N 123.496 0.498 . . . . 0.0 110.285 -171.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.49 -96.53 0.35 Allowed Glycine 0 C--N 1.307 -1.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.688 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 t -75.81 71.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.36 87.32 1.52 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.105 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.51 114.43 26.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 p -167.28 94.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.163 0.506 . . . . 0.0 110.312 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.396 179.317 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.17 0.509 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.8 147.75 26.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.1 p -107.44 136.92 19.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 73.57 5.84 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.389 2.059 . . . . 0.0 111.462 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.566 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -64.45 147.13 53.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.533 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.1 m -51.15 136.62 23.64 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 3.9 p90 40.24 74.49 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.338 1.024 . . . . 0.0 110.659 -165.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.72 -23.79 62.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 -172.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 37.6 t80 -173.06 -50.97 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.361 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 62.1 Cg_endo -111.38 16.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.839 2.359 . . . . 0.0 113.369 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.821 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.9 p30 41.08 -112.84 0.16 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 110.215 -166.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.43 -81.93 0.48 Allowed Glycine 0 C--N 1.309 -0.929 0 O-C-N 123.68 0.613 . . . . 0.0 112.459 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.15 87.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 14' ' ' LEU . 2.8 mp -87.47 63.91 7.9 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.17 90.8 4.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.198 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 m -110.65 -33.6 6.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.99 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.504 179.228 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.839 0.352 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.05 114.51 4.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.18 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -84.87 132.4 46.16 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.921 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.5 94.02 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.207 2.604 . . . . 0.0 113.12 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.612 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.8 159.61 27.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.036 175.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.5 m -54.18 134.21 44.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.481 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.451 ' HA ' ' CA ' ' A' ' 11' ' ' ASN . 8.3 p90 40.35 61.57 1.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.092 0.87 . . . . 0.0 111.417 -170.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.927 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -64.74 -36.0 82.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.453 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.676 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.2 t80 -159.7 -53.26 0.01 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.375 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 84.6 Cg_endo -102.84 -15.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.191 1.927 . . . . 0.0 113.433 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CA ' ' HA ' ' A' ' 7' ' ' PHE . 60.9 t30 69.58 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.491 ' O ' HD12 ' A' ' 14' ' ' LEU . . . 46.35 -109.66 0.39 Allowed Glycine 0 C--N 1.31 -0.87 0 O-C-N 124.828 1.33 . . . . 0.0 114.012 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.21 86.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.913 0.863 . . . . 0.0 109.538 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.927 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.4 mp -64.1 117.37 7.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.817 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.73 25.88 9.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.68 138.94 31.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.165 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.357 -179.226 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.003 0.43 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.89 122.83 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.746 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -101.72 121.26 51.73 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.37 128.89 31.07 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.798 2.332 . . . . 0.0 113.353 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.56 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -107.22 154.98 20.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -39.36 -68.04 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.073 0.858 . . . . 0.0 111.741 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 11.3 p90 -91.6 92.25 8.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 168.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.751 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 5.4 ptp180 -83.92 -26.23 29.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.039 0.923 . . . . 0.0 109.535 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.618 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 74.3 t80 -176.86 -43.96 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.751 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 61.6 Cg_endo -98.54 157.63 0.74 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.183 1.922 . . . . 0.0 111.323 153.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.508 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 19.1 p30 -110.36 23.45 14.26 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 -82.73 0.16 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.031 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.85 69.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.594 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.41 71.74 1.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.576 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' N ' HH22 ' A' ' 8' ' ' ARG . . . -84.76 108.19 17.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -109.81 -63.95 1.31 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.809 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.731 -179.044 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.29 125.73 28.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 111.334 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 19.9 m -109.36 140.65 22.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 176.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 5.6 Cg_exo -69.8 103.79 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 111.594 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 12.3 mptt -59.4 150.84 25.25 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -43.1 -48.19 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.295 0.372 . . . . 0.0 111.052 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.863 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.2 p90 -114.47 79.11 1.22 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 167.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.047 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -69.92 -27.06 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.319 0.58 . . . . 0.0 109.945 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 39.4 t80 -168.7 -51.86 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.587 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.0 Cg_endo -104.19 -8.66 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.672 2.248 . . . . 0.0 114.096 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.863 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 44.47 45.91 7.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.416 0.686 . . . . 0.0 111.386 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.67 -82.71 1.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.178 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -94.87 90.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.047 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.3 mp -69.82 125.47 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.879 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.96 34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.465 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -78.28 -68.83 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.491 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.437 179.808 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.63 144.44 46.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.835 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -74.19 139.49 75.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.039 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.11 70.98 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.541 2.828 . . . . 0.0 113.496 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.19 162.18 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -51.89 133.42 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 4.8 p90 40.32 70.2 0.26 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.066 0.936 . . . . 0.0 111.074 -168.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.766 HH12 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -72.1 -31.25 65.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.046 -172.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.62 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 58.2 t80 -162.19 -43.63 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 19.0 Cg_endo -95.18 -80.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.234 1.956 . . . . 0.0 109.935 159.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 64.0 t30 151.02 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 11' ' ' ASN . . . 50.34 -122.36 12.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.149 168.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.89 88.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.656 0.741 . . . . 0.0 109.845 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.766 ' HA ' HH12 ' A' ' 8' ' ' ARG . 3.4 mp -67.66 133.53 49.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.481 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.28 23.53 14.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.739 0.78 . . . . 0.0 109.214 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 14' ' ' LEU . 25.3 p -116.38 136.8 52.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.819 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.006 177.15 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 61.4 t80 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.79 165.5 25.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.277 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -75.6 154.04 85.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.025 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 91.8 Cg_exo -46.07 112.83 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.443 2.762 . . . . 0.0 114.041 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.13 113.01 18.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 175.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' HD23 ' A' ' 14' ' ' LEU . 86.3 m 45.29 -90.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.21 -173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -86.05 85.7 7.36 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 176.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' NH2' ' H ' ' A' ' 15' ' ' ALA . 2.9 ptp180 -77.52 -8.29 57.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 56.8 t80 179.68 -58.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.209 169.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 86.3 Cg_endo -105.41 -1.81 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.219 1.946 . . . . 0.0 114.029 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 7.8 p30 56.25 18.61 3.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.854 0.862 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 -71.9 1.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.421 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 8' ' ' ARG . 2.9 p -74.63 100.45 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.512 0.672 . . . . 0.0 109.577 172.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 6' ' ' CYS . 72.9 mt -100.35 131.7 46.13 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.276 0.56 . . . . 0.0 111.525 -174.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' H ' ' NH2' ' A' ' 8' ' ' ARG . . . -147.3 115.58 6.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.66 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 m -138.11 -60.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.222 0.534 . . . . 0.0 109.955 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.869 177.578 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.25 125.78 20.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -78.82 120.04 79.45 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.765 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.55 79.91 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.797 2.331 . . . . 0.0 112.5 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.61 151.89 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.379 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -58.03 137.37 56.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.822 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 4.6 p90 40.77 73.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.268 0.98 . . . . 0.0 110.857 -163.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 1.1 ptp180 -70.96 -19.31 62.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.891 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 65.9 t80 -172.29 -54.25 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.468 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.9 Cg_endo -99.63 -17.08 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.095 1.863 . . . . 0.0 113.759 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 70.59 0.73 3.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.3 0.64 . . . . 0.0 111.535 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.88 -72.3 0.68 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.344 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -93.46 84.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.709 0.766 . . . . 0.0 109.854 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.6 75.65 7.46 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.37 0.605 . . . . 0.0 111.396 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.17 88.78 7.51 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.3 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.58 19.46 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.501 -178.574 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 55.9 p90 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.82 147.26 46.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.704 0.287 . . . . 0.0 110.912 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 51.0 m -90.03 128.4 49.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.792 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 10.6 Cg_exo -67.98 99.8 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.2 1.933 . . . . 0.0 111.598 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.593 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -84.45 140.95 31.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.255 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -51.62 135.77 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.805 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.3 p90 38.29 74.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.08 0.862 . . . . 0.0 111.214 -165.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -18.82 61.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.397 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 7.1 t80 -175.25 -55.2 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.701 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 74.0 Cg_endo -103.4 -1.62 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.633 2.222 . . . . 0.0 114.206 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 41.79 36.22 0.6 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.37 0.668 . . . . 0.0 112.735 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 -53.43 3.98 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.867 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.68 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.69 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp -82.54 71.09 9.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.166 0.508 . . . . 0.0 110.819 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.39 102.5 14.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 p -161.76 -39.66 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.7 m . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.111 176.342 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.79 164.74 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.359 0.6 . . . . 0.0 111.927 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -152.01 131.32 6.72 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.057 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' ARG . 60.9 Cg_endo -71.43 70.33 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.702 2.268 . . . . 0.0 113.667 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -69.86 159.17 34.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -58.56 138.32 56.88 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.342 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 5.9 p90 41.21 65.23 0.85 Allowed 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 124.093 0.871 . . . . 0.0 111.603 -168.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.817 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -73.91 -21.56 60.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.648 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 62.2 t80 -170.2 -53.94 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.449 173.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 70.0 Cg_endo -99.01 -25.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.777 1.651 . . . . 0.0 114.296 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 8.5 t30 63.94 36.6 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.95 0.881 . . . . 0.0 109.045 -173.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.25 -106.79 0.51 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.602 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.03 95.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.731 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.817 ' HA ' HH22 ' A' ' 8' ' ' ARG . 84.8 mt -83.24 109.49 17.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.993 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.04 32.09 6.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.559 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.83 130.32 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.792 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.463 -0.779 . . . . 0.0 109.84 178.926 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.71 154.9 18.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -98.04 138.12 20.92 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.729 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 36.5 Cg_endo -66.55 86.33 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.593 2.196 . . . . 0.0 112.082 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.77 155.38 31.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.94 -178.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.9 m -51.64 136.68 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.097 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.826 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 7.3 p90 39.41 68.74 0.34 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.0 -167.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.546 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -64.24 -25.79 68.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.854 -174.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 49.8 t80 -169.39 -52.58 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.668 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 53.4 Cg_endo -108.59 20.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.999 2.466 . . . . 0.0 113.023 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.826 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 8.3 p30 44.04 -105.41 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.818 0.699 . . . . 0.0 110.78 -171.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 68.23 -107.2 1.97 Allowed Glycine 0 C--N 1.302 -1.313 0 O-C-N 123.571 0.544 . . . . 0.0 112.36 172.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 13' ' ' VAL . 3.4 p -83.18 87.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 7' ' ' PHE . 4.9 mp -81.18 74.55 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.43 89.44 7.4 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.76 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p -140.25 16.15 2.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.465 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 C--O 1.247 0.972 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.9 179.525 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 53.2 p90 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.782 0.325 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.85 -2.51 15.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.456 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.8 m 63.66 141.57 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.737 0.779 . . . . 0.0 112.097 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -83.95 111.16 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.714 2.276 . . . . 0.0 113.191 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 9.7 mptt -79.98 144.38 33.33 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.56 ' O ' HD23 ' A' ' 14' ' ' LEU . 95.4 m -47.33 -56.3 7.12 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.272 0.358 . . . . 0.0 110.615 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.827 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 5.5 p90 -101.84 77.96 1.77 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.653 0.74 . . . . 0.0 109.079 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -60.66 -25.77 66.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.909 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.594 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 14.9 t80 -167.75 -57.45 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.256 168.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 45.4 Cg_endo -104.02 2.74 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.553 2.169 . . . . 0.0 113.432 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.827 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.5 p-10 47.26 28.71 1.07 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.819 0.848 . . . . 0.0 112.165 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.48 -66.36 1.56 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.415 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.5 p -84.18 83.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.012 0.911 . . . . 0.0 109.408 174.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 6' ' ' CYS . 51.9 mt -76.5 81.23 3.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.951 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.11 93.12 4.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.5 p -140.3 7.61 2.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.59 . . . . 0.0 110.067 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.246 0.878 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.131 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 33.1 t80 . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.355 0.597 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.7 135.45 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.03 -0.419 . . . . 0.0 110.983 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p -67.99 140.2 93.49 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.52 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 128.29 17.37 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.701 2.267 . . . . 0.0 113.116 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 1.5 mppt? -96.6 173.55 7.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 58.8 m -43.71 -61.12 1.51 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.557 0.617 . . . . 0.0 110.224 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.923 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 4.9 p90 -92.0 87.91 6.37 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.688 0.756 . . . . 0.0 109.132 167.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.5 ptp180 -71.8 -33.95 68.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.337 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 4.5 t80 -165.76 -51.37 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.738 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 69.6 Cg_endo -101.16 -7.55 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.238 1.959 . . . . 0.0 114.321 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.6 p-10 48.26 31.0 2.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.156 0.582 . . . . 0.0 111.541 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.72 -74.85 1.15 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.36 67.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.609 1.195 . . . . 0.0 109.921 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -93.92 151.41 19.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.149 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.66 26.26 5.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p -94.15 -3.71 50.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.014 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.567 -178.767 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.87 128.82 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -81.35 138.78 48.26 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.6 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.03 76.63 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.09 2.527 . . . . 0.0 112.674 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -56.36 148.57 18.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.108 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.96 139.76 57.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.803 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.681 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 13.8 p90 38.54 66.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.663 1.227 . . . . 0.0 110.691 -165.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.701 HH21 HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -55.71 -27.15 48.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.796 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 67.8 t80 -168.06 -53.04 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.84 169.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 97.6 Cg_endo -103.48 -4.25 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.489 2.126 . . . . 0.0 113.895 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.681 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 1.9 p-10 49.84 19.13 0.4 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.795 . . . . 0.0 111.743 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -68.62 1.56 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 8' ' ' ARG . 28.9 m -78.13 142.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 HH21 ' A' ' 8' ' ' ARG . 85.7 mt -136.96 101.82 4.68 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.03 53.78 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.239 0.543 . . . . 0.0 111.072 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -146.69 -167.49 2.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.665 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.638 178.117 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.728 0.299 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.2 86.67 5.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.159 0.504 . . . . 0.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 12.9 m -82.96 128.23 66.34 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.384 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 3' ' ' SER . 3.5 Cg_exo -77.37 103.6 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.971 2.448 . . . . 0.0 111.882 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -84.58 155.58 22.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.864 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -57.4 134.35 55.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.766 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 8.2 p90 42.71 80.92 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.682 1.239 . . . . 0.0 110.986 -161.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.3 ptp180 -80.56 -88.82 0.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.559 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.565 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 17.2 t80 -100.29 -44.05 0.22 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 161.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.701 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 44.1 Cg_endo -104.28 144.85 0.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.787 2.325 . . . . 0.0 111.666 163.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 1.2 t30 -90.18 13.77 14.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.607 1.194 . . . . 0.0 108.805 171.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.7 -84.12 0.3 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.613 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 94.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 11' ' ' ASN . 69.0 mt -100.7 89.3 3.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.847 -174.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.63 101.19 12.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.7 p -172.91 -27.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.387 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.3 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.197 178.421 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 120.287 0.089 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.73 -141.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.907 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t 72.25 116.68 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 123.591 0.756 . . . . 0.0 110.571 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 152.24 53.83 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.969 2.446 . . . . 0.0 112.969 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -140.68 157.43 45.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.074 178.624 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.45 139.43 55.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 19.2 p90 43.08 70.41 0.3 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.233 1.016 . . . . 0.0 110.258 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -75.99 -18.19 59.4 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.907 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 11.3 t80 -165.16 -46.07 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.355 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 59.0 Cg_endo -101.06 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.49 2.126 . . . . 0.0 110.882 167.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 19.9 p-10 155.58 4.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.924 1.29 . . . . 0.0 108.09 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' H ' ' H ' ' A' ' 11' ' ' ASN . . . -58.6 -81.46 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.598 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.92 99.59 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.933 0.873 . . . . 0.0 109.919 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 11' ' ' ASN . 34.3 mt -92.3 75.02 5.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 95.76 10.3 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.841 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.7 m -123.14 -38.38 2.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.146 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.246 0.901 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.169 -176.32 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.1 p90 . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.707 0.289 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.31 76.21 3.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.379 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.3 p -93.6 111.49 52.67 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.882 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.53 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 7.4 Cg_exo -71.48 118.0 5.44 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.793 2.328 . . . . 0.0 112.136 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.6 153.56 29.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.682 -176.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.2 m -53.51 133.57 40.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 p90 43.47 75.89 0.09 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.342 1.068 . . . . 0.0 111.291 -162.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.575 HH12 ' H ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -76.29 -21.57 56.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.764 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 2.4 t80 -179.83 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 95.9 Cg_endo -102.82 -16.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.158 1.905 . . . . 0.0 113.255 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 t30 63.18 -149.46 0.34 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -171.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.0 -70.66 3.09 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.716 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -93.55 77.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.757 0.789 . . . . 0.0 109.407 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.01 91.05 6.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.713 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' H ' HH12 ' A' ' 8' ' ' ARG . . . -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.255 0.55 . . . . 0.0 110.141 170.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 p -148.64 29.56 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.153 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.673 -177.449 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.877 0.37 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.49 100.58 10.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.912 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p -79.51 129.29 72.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 24.4 Cg_endo -64.53 96.41 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.856 2.371 . . . . 0.0 112.394 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -81.99 169.97 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.382 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -55.86 135.83 51.79 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 12.7 p90 38.97 67.07 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.591 1.182 . . . . 0.0 110.854 -164.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.575 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -57.45 -26.37 61.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.822 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 35.3 t80 -171.9 -55.62 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.37 168.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 56.9 Cg_endo -99.9 -2.81 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.89 1.726 . . . . 0.0 114.397 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 9.3 p30 49.52 29.39 2.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.65 0.78 . . . . 0.0 112.478 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.15 -64.75 1.57 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.818 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.0 p -88.89 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.328 1.061 . . . . 0.0 109.29 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.33 113.77 24.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.447 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.67 -58.43 1.83 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.0 m 67.39 100.92 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.851 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.774 178.733 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 121.019 0.438 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.48 134.33 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.042 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -64.87 141.62 98.4 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 73.6 Cg_endo -75.71 58.21 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.814 2.343 . . . . 0.0 112.408 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.72 153.32 43.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -58.2 150.25 22.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.822 -174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 18.5 p90 39.92 54.46 2.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.046 0.927 . . . . 0.0 110.999 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.516 HH12 ' HB3' ' A' ' 15' ' ' ALA . 3.0 ptp180 -59.9 -27.02 66.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.894 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.1 t80 -161.96 -54.36 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.8 167.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 83.0 Cg_endo -105.5 -8.32 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.017 1.811 . . . . 0.0 114.179 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 4.2 p30 53.0 15.77 0.63 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.498 0.719 . . . . 0.0 111.966 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.89 -62.66 2.92 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -83.74 137.48 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 169.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.59 158.78 39.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.944 0.402 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -168.94 49.11 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.996 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.5 p -143.06 86.12 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.165 0.507 . . . . 0.0 111.997 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.255 -0.879 . . . . 0.0 109.601 175.223 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.649 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 20.6 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.73 47.48 2.58 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 113.185 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.649 ' HD3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.69 141.88 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' HB3' HD23 ' A' ' 14' ' ' LEU . 95.7 m -33.3 -62.66 0.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.038 . . . . 0.0 113.338 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -100.72 72.04 1.51 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.46 0.648 . . . . 0.0 110.047 173.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.59 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 3.5 ptp180 -64.98 -24.54 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.59 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 36.9 t80 -175.96 -50.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.758 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 60.2 Cg_endo -97.3 -26.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.741 1.628 . . . . 0.0 113.437 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.849 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 19.8 t30 64.98 31.78 11.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 110.109 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.86 -70.18 1.35 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.841 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.08 87.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.9 mp -77.24 84.34 3.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 69.67 3.0 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.935 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.7 m . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.675 -178.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.41 104.38 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.912 2.408 . . . . 0.0 113.043 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.68 168.01 15.66 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.9 m -41.75 -64.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.355 0.525 . . . . 0.0 111.519 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 9.0 p90 -95.25 86.03 4.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -67.14 -30.4 70.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 110.299 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 91.5 t80 -169.19 -51.87 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.683 173.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 93.8 Cg_endo -110.71 19.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 122.448 2.099 . . . . 0.0 112.366 173.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.7 p30 43.1 -107.77 0.1 Allowed 'General case' 0 C--N 1.347 0.5 0 O-C-N 123.496 0.498 . . . . 0.0 110.285 -171.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.49 -96.53 0.35 Allowed Glycine 0 C--N 1.307 -1.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.688 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 t -75.81 71.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.36 87.32 1.52 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.105 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.51 114.43 26.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 121.163 0.506 . . . . 0.0 110.312 -179.365 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 73.57 5.84 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.389 2.059 . . . . 0.0 111.462 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.566 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -64.45 147.13 53.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.533 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.1 m -51.15 136.62 23.64 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 3.9 p90 40.24 74.49 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.338 1.024 . . . . 0.0 110.659 -165.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.72 -23.79 62.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 -172.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 37.6 t80 -173.06 -50.97 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.361 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 62.1 Cg_endo -111.38 16.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.839 2.359 . . . . 0.0 113.369 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.821 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.9 p30 41.08 -112.84 0.16 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 110.215 -166.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.43 -81.93 0.48 Allowed Glycine 0 C--N 1.309 -0.929 0 O-C-N 123.68 0.613 . . . . 0.0 112.459 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.15 87.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 14' ' ' LEU . 2.8 mp -87.47 63.91 7.9 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.17 90.8 4.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.198 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.99 178.75 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.5 94.02 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.207 2.604 . . . . 0.0 113.12 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.612 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.8 159.61 27.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.036 175.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.5 m -54.18 134.21 44.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.481 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.451 ' HA ' ' CA ' ' A' ' 11' ' ' ASN . 8.3 p90 40.35 61.57 1.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.092 0.87 . . . . 0.0 111.417 -170.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.927 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -64.74 -36.0 82.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.453 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.676 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.2 t80 -159.7 -53.26 0.01 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.375 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 84.6 Cg_endo -102.84 -15.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.191 1.927 . . . . 0.0 113.433 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CA ' ' HA ' ' A' ' 7' ' ' PHE . 60.9 t30 69.58 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.491 ' O ' HD12 ' A' ' 14' ' ' LEU . . . 46.35 -109.66 0.39 Allowed Glycine 0 C--N 1.31 -0.87 0 O-C-N 124.828 1.33 . . . . 0.0 114.012 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.21 86.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.913 0.863 . . . . 0.0 109.538 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.927 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.4 mp -64.1 117.37 7.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.817 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.73 25.88 9.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.165 -178.448 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.37 128.89 31.07 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.798 2.332 . . . . 0.0 113.353 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.56 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -107.22 154.98 20.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -39.36 -68.04 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.073 0.858 . . . . 0.0 111.741 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 11.3 p90 -91.6 92.25 8.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 168.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.751 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 5.4 ptp180 -83.92 -26.23 29.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.039 0.923 . . . . 0.0 109.535 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.618 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 74.3 t80 -176.86 -43.96 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.751 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 61.6 Cg_endo -98.54 157.63 0.74 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.183 1.922 . . . . 0.0 111.323 153.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.508 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 19.1 p30 -110.36 23.45 14.26 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 -82.73 0.16 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.031 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.85 69.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.594 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.41 71.74 1.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.576 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' N ' HH22 ' A' ' 8' ' ' ARG . . . -84.76 108.19 17.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.809 -174.458 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 19.9 m . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 5.6 Cg_exo -69.8 103.79 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 111.594 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 12.3 mptt -59.4 150.84 25.25 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -43.1 -48.19 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.295 0.372 . . . . 0.0 111.052 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.863 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.2 p90 -114.47 79.11 1.22 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 167.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 1.047 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -69.92 -27.06 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.319 0.58 . . . . 0.0 109.945 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 39.4 t80 -168.7 -51.86 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.587 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.0 Cg_endo -104.19 -8.66 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.672 2.248 . . . . 0.0 114.096 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.863 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 44.47 45.91 7.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.416 0.686 . . . . 0.0 111.386 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.67 -82.71 1.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.178 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -94.87 90.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.047 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.3 mp -69.82 125.47 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.879 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.96 34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.465 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.491 -177.077 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.366 0.127 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.11 70.98 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.541 2.828 . . . . 0.0 113.496 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.19 162.18 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -51.89 133.42 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 4.8 p90 40.32 70.2 0.26 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.066 0.936 . . . . 0.0 111.074 -168.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.766 HH12 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -72.1 -31.25 65.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.046 -172.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.62 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 58.2 t80 -162.19 -43.63 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 19.0 Cg_endo -95.18 -80.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.234 1.956 . . . . 0.0 109.935 159.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 64.0 t30 151.02 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 11' ' ' ASN . . . 50.34 -122.36 12.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.149 168.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.89 88.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.656 0.741 . . . . 0.0 109.845 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.766 ' HA ' HH12 ' A' ' 8' ' ' ARG . 3.4 mp -67.66 133.53 49.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.481 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.28 23.53 14.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.739 0.78 . . . . 0.0 109.214 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 14' ' ' LEU . 25.3 p . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.819 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 91.8 Cg_exo -46.07 112.83 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.443 2.762 . . . . 0.0 114.041 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.5 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.13 113.01 18.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 175.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' HD23 ' A' ' 14' ' ' LEU . 86.3 m 45.29 -90.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.21 -173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -86.05 85.7 7.36 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 176.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' NH2' ' H ' ' A' ' 15' ' ' ALA . 2.9 ptp180 -77.52 -8.29 57.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 56.8 t80 179.68 -58.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.209 169.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 86.3 Cg_endo -105.41 -1.81 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.219 1.946 . . . . 0.0 114.029 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 7.8 p30 56.25 18.61 3.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.854 0.862 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 -71.9 1.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.421 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 8' ' ' ARG . 2.9 p -74.63 100.45 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.512 0.672 . . . . 0.0 109.577 172.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 6' ' ' CYS . 72.9 mt -100.35 131.7 46.13 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.276 0.56 . . . . 0.0 111.525 -174.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.593 ' H ' ' NH2' ' A' ' 8' ' ' ARG . . . -147.3 115.58 6.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.66 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.222 0.534 . . . . 0.0 109.955 -176.421 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.445 -0.681 0 CA-C-O 120.92 0.391 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.55 79.91 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.797 2.331 . . . . 0.0 112.5 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.61 151.89 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.379 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -58.03 137.37 56.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.822 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 4.6 p90 40.77 73.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.268 0.98 . . . . 0.0 110.857 -163.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 1.1 ptp180 -70.96 -19.31 62.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.891 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 65.9 t80 -172.29 -54.25 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.468 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.9 Cg_endo -99.63 -17.08 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.095 1.863 . . . . 0.0 113.759 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.1 OUTLIER 70.59 0.73 3.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.3 0.64 . . . . 0.0 111.535 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.88 -72.3 0.68 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.344 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -93.46 84.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.709 0.766 . . . . 0.0 109.854 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.6 75.65 7.46 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.37 0.605 . . . . 0.0 111.396 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.17 88.78 7.51 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.3 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.132 178.11 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 51.0 m . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 10.6 Cg_exo -67.98 99.8 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.2 1.933 . . . . 0.0 111.598 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.593 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -84.45 140.95 31.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.255 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -51.62 135.77 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.805 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.3 p90 38.29 74.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.08 0.862 . . . . 0.0 111.214 -165.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -18.82 61.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.397 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 7.1 t80 -175.25 -55.2 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.701 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 74.0 Cg_endo -103.4 -1.62 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.633 2.222 . . . . 0.0 114.206 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 41.79 36.22 0.6 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.37 0.668 . . . . 0.0 112.735 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 -53.43 3.98 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.867 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.68 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.69 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp -82.54 71.09 9.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.166 0.508 . . . . 0.0 110.819 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.39 102.5 14.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.696 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' ARG . 60.9 Cg_endo -71.43 70.33 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.702 2.268 . . . . 0.0 113.667 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.526 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -69.86 159.17 34.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -58.56 138.32 56.88 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.342 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 5.9 p90 41.21 65.23 0.85 Allowed 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 124.093 0.871 . . . . 0.0 111.603 -168.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.817 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -73.91 -21.56 60.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.648 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 62.2 t80 -170.2 -53.94 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.449 173.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 70.0 Cg_endo -99.01 -25.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.777 1.651 . . . . 0.0 114.296 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 8.5 t30 63.94 36.6 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.95 0.881 . . . . 0.0 109.045 -173.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.25 -106.79 0.51 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.602 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.03 95.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.731 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.817 ' HA ' HH22 ' A' ' 8' ' ' ARG . 84.8 mt -83.24 109.49 17.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.993 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.04 32.09 6.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.559 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.792 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 36.5 Cg_endo -66.55 86.33 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.593 2.196 . . . . 0.0 112.082 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.77 155.38 31.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.94 -178.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.9 m -51.64 136.68 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.097 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.826 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 7.3 p90 39.41 68.74 0.34 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.0 -167.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.546 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -64.24 -25.79 68.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.854 -174.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 49.8 t80 -169.39 -52.58 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.668 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 53.4 Cg_endo -108.59 20.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.999 2.466 . . . . 0.0 113.023 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.826 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 8.3 p30 44.04 -105.41 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.818 0.699 . . . . 0.0 110.78 -171.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 68.23 -107.2 1.97 Allowed Glycine 0 C--N 1.302 -1.313 0 O-C-N 123.571 0.544 . . . . 0.0 112.36 172.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 13' ' ' VAL . 3.4 p -83.18 87.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 7' ' ' PHE . 4.9 mp -81.18 74.55 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.43 89.44 7.4 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.76 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.465 179.606 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.737 0.779 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -83.95 111.16 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.714 2.276 . . . . 0.0 113.191 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 9.7 mptt -79.98 144.38 33.33 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.56 ' O ' HD23 ' A' ' 14' ' ' LEU . 95.4 m -47.33 -56.3 7.12 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.272 0.358 . . . . 0.0 110.615 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.827 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 5.5 p90 -101.84 77.96 1.77 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.653 0.74 . . . . 0.0 109.079 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -60.66 -25.77 66.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.909 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.594 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 14.9 t80 -167.75 -57.45 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.256 168.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 45.4 Cg_endo -104.02 2.74 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.553 2.169 . . . . 0.0 113.432 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.827 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.5 p-10 47.26 28.71 1.07 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.819 0.848 . . . . 0.0 112.165 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.48 -66.36 1.56 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.415 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.5 p -84.18 83.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.012 0.911 . . . . 0.0 109.408 174.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 6' ' ' CYS . 51.9 mt -76.5 81.23 3.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.951 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.11 93.12 4.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.5 p . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.59 . . . . 0.0 110.067 177.721 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.712 0.291 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 128.29 17.37 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.701 2.267 . . . . 0.0 113.116 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 1.5 mppt? -96.6 173.55 7.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 58.8 m -43.71 -61.12 1.51 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.557 0.617 . . . . 0.0 110.224 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.923 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 4.9 p90 -92.0 87.91 6.37 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.688 0.756 . . . . 0.0 109.132 167.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.5 ptp180 -71.8 -33.95 68.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.337 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 4.5 t80 -165.76 -51.37 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.738 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 69.6 Cg_endo -101.16 -7.55 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.238 1.959 . . . . 0.0 114.321 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.6 p-10 48.26 31.0 2.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.156 0.582 . . . . 0.0 111.541 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.72 -74.85 1.15 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.36 67.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.609 1.195 . . . . 0.0 109.921 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -93.92 151.41 19.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.149 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.66 26.26 5.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.014 -179.56 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.03 76.63 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.09 2.527 . . . . 0.0 112.674 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -56.36 148.57 18.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.108 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.96 139.76 57.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.803 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.681 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 13.8 p90 38.54 66.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.663 1.227 . . . . 0.0 110.691 -165.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.701 HH21 HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -55.71 -27.15 48.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.796 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 67.8 t80 -168.06 -53.04 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.84 169.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 97.6 Cg_endo -103.48 -4.25 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.489 2.126 . . . . 0.0 113.895 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.681 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 1.9 p-10 49.84 19.13 0.4 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.795 . . . . 0.0 111.743 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -68.62 1.56 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 8' ' ' ARG . 28.9 m -78.13 142.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 HH21 ' A' ' 8' ' ' ARG . 85.7 mt -136.96 101.82 4.68 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.03 53.78 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.239 0.543 . . . . 0.0 111.072 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.665 -179.709 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 12.9 m . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 3' ' ' SER . 3.5 Cg_exo -77.37 103.6 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.971 2.448 . . . . 0.0 111.882 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -84.58 155.58 22.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.864 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -57.4 134.35 55.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.766 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 8.2 p90 42.71 80.92 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.682 1.239 . . . . 0.0 110.986 -161.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.3 ptp180 -80.56 -88.82 0.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.559 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.565 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 17.2 t80 -100.29 -44.05 0.22 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 161.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.701 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 44.1 Cg_endo -104.28 144.85 0.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.787 2.325 . . . . 0.0 111.666 163.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 2.0 t-20 -90.18 13.77 14.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.607 1.194 . . . . 0.0 108.805 171.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.7 -84.12 0.3 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.613 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 94.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 11' ' ' ASN . 69.0 mt -100.7 89.3 3.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.847 -174.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.63 101.19 12.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.387 -177.459 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.171 0.51 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 152.24 53.83 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.969 2.446 . . . . 0.0 112.969 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -140.68 157.43 45.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.074 178.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.45 139.43 55.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 19.2 p90 43.08 70.41 0.3 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.233 1.016 . . . . 0.0 110.258 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -75.99 -18.19 59.4 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.907 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 11.3 t80 -165.16 -46.07 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.355 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 59.0 Cg_endo -101.06 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.49 2.126 . . . . 0.0 110.882 167.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 19.9 p-10 155.58 4.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.924 1.29 . . . . 0.0 108.09 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' H ' ' H ' ' A' ' 11' ' ' ASN . . . -58.6 -81.46 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.598 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.92 99.59 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.933 0.873 . . . . 0.0 109.919 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 11' ' ' ASN . 34.3 mt -92.3 75.02 5.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 95.76 10.3 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.841 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.146 178.791 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.3 p . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.53 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 7.4 Cg_exo -71.48 118.0 5.44 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.793 2.328 . . . . 0.0 112.136 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.6 153.56 29.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.682 -176.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.2 m -53.51 133.57 40.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 p90 43.47 75.89 0.09 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.342 1.068 . . . . 0.0 111.291 -162.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.575 HH12 ' H ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -76.29 -21.57 56.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.764 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 2.4 t80 -179.83 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 95.9 Cg_endo -102.82 -16.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.158 1.905 . . . . 0.0 113.255 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.412 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 t30 63.18 -149.46 0.34 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -171.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.0 -70.66 3.09 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.716 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -93.55 77.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.757 0.789 . . . . 0.0 109.407 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.01 91.05 6.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.713 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.575 ' H ' HH12 ' A' ' 8' ' ' ARG . . . -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.255 0.55 . . . . 0.0 110.141 170.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 p . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.153 178.017 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.649 0.261 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 24.4 Cg_endo -64.53 96.41 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.856 2.371 . . . . 0.0 112.394 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -81.99 169.97 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.382 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -55.86 135.83 51.79 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 12.7 p90 38.97 67.07 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.591 1.182 . . . . 0.0 110.854 -164.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.575 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -57.45 -26.37 61.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.822 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 35.3 t80 -171.9 -55.62 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.37 168.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 56.9 Cg_endo -99.9 -2.81 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.89 1.726 . . . . 0.0 114.397 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 9.3 p30 49.52 29.39 2.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.65 0.78 . . . . 0.0 112.478 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.15 -64.75 1.57 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.818 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.0 p -88.89 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.328 1.061 . . . . 0.0 109.29 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.33 113.77 24.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.447 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.67 -58.43 1.83 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.851 175.463 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 73.6 Cg_endo -75.71 58.21 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.814 2.343 . . . . 0.0 112.408 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.72 153.32 43.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -58.2 150.25 22.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.822 -174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 18.5 p90 39.92 54.46 2.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.046 0.927 . . . . 0.0 110.999 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.516 HH12 ' HB3' ' A' ' 15' ' ' ALA . 3.0 ptp180 -59.9 -27.02 66.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.894 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.1 t80 -161.96 -54.36 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.8 167.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 83.0 Cg_endo -105.5 -8.32 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.017 1.811 . . . . 0.0 114.179 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 4.2 p30 53.0 15.77 0.63 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.498 0.719 . . . . 0.0 111.966 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.89 -62.66 2.92 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -83.74 137.48 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 169.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.59 158.78 39.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.944 0.402 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -168.94 49.11 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.996 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.165 0.507 . . . . 0.0 111.997 -174.136 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.718 0.294 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.6 166.6 12.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.364 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.649 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 20.6 t -95.77 142.37 24.48 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.225 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.73 47.48 2.58 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 113.185 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.649 ' HD3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.69 141.88 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' HB3' HD23 ' A' ' 14' ' ' LEU . 95.7 m -33.3 -62.66 0.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.038 . . . . 0.0 113.338 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -100.72 72.04 1.51 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.46 0.648 . . . . 0.0 110.047 173.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.59 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 3.5 ptp180 -64.98 -24.54 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.59 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 36.9 t80 -175.96 -50.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.758 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 60.2 Cg_endo -97.3 -26.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.741 1.628 . . . . 0.0 113.437 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.849 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 19.8 t30 64.98 31.78 11.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 110.109 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.86 -70.18 1.35 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.841 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.08 87.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.9 mp -77.24 84.34 3.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 69.67 3.0 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.935 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.7 m -112.01 -54.05 2.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.675 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.062 179.018 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.1 t80 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.816 0.341 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.73 121.53 20.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -150.56 108.02 3.12 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.594 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.41 104.38 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.912 2.408 . . . . 0.0 113.043 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.68 168.01 15.66 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.9 m -41.75 -64.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.355 0.525 . . . . 0.0 111.519 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 9.0 p90 -95.25 86.03 4.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -67.14 -30.4 70.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 110.299 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 91.5 t80 -169.19 -51.87 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.683 173.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 93.8 Cg_endo -110.71 19.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 122.448 2.099 . . . . 0.0 112.366 173.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.7 p30 43.1 -107.77 0.1 Allowed 'General case' 0 C--N 1.347 0.5 0 O-C-N 123.496 0.498 . . . . 0.0 110.285 -171.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.49 -96.53 0.35 Allowed Glycine 0 C--N 1.307 -1.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.688 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 t -75.81 71.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.36 87.32 1.52 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.105 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.51 114.43 26.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 p -167.28 94.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.163 0.506 . . . . 0.0 110.312 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.396 179.317 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.17 0.509 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.8 147.75 26.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.1 p -107.44 136.92 19.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 73.57 5.84 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.389 2.059 . . . . 0.0 111.462 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.566 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -64.45 147.13 53.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.533 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.1 m -51.15 136.62 23.64 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 3.9 p90 40.24 74.49 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.338 1.024 . . . . 0.0 110.659 -165.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.72 -23.79 62.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 -172.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 37.6 t80 -173.06 -50.97 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.361 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 62.1 Cg_endo -111.38 16.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.839 2.359 . . . . 0.0 113.369 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.821 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 4.9 p30 41.08 -112.84 0.16 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 110.215 -166.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.43 -81.93 0.48 Allowed Glycine 0 C--N 1.309 -0.929 0 O-C-N 123.68 0.613 . . . . 0.0 112.459 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.15 87.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 14' ' ' LEU . 2.8 mp -87.47 63.91 7.9 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.17 90.8 4.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.198 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 m -110.65 -33.6 6.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.99 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.504 179.228 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.839 0.352 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.05 114.51 4.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.18 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -84.87 132.4 46.16 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.921 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.5 94.02 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.207 2.604 . . . . 0.0 113.12 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.612 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.8 159.61 27.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.036 175.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.5 m -54.18 134.21 44.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.481 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.451 ' HA ' ' CA ' ' A' ' 11' ' ' ASN . 8.3 p90 40.35 61.57 1.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.092 0.87 . . . . 0.0 111.417 -170.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.927 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -64.74 -36.0 82.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.453 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.676 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.2 t80 -159.7 -53.26 0.01 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.375 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 84.6 Cg_endo -102.84 -15.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.191 1.927 . . . . 0.0 113.433 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CA ' ' HA ' ' A' ' 7' ' ' PHE . 60.9 t30 69.58 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.491 ' O ' HD12 ' A' ' 14' ' ' LEU . . . 46.35 -109.66 0.39 Allowed Glycine 0 C--N 1.31 -0.87 0 O-C-N 124.828 1.33 . . . . 0.0 114.012 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.21 86.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.913 0.863 . . . . 0.0 109.538 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.927 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.4 mp -64.1 117.37 7.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.817 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.73 25.88 9.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.68 138.94 31.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.165 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.357 -179.226 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.003 0.43 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.89 122.83 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.746 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -101.72 121.26 51.73 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.37 128.89 31.07 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.798 2.332 . . . . 0.0 113.353 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.56 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -107.22 154.98 20.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -39.36 -68.04 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.073 0.858 . . . . 0.0 111.741 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 11.3 p90 -91.6 92.25 8.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 168.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.751 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 5.4 ptp180 -83.92 -26.23 29.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.039 0.923 . . . . 0.0 109.535 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.618 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 74.3 t80 -176.86 -43.96 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.751 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 61.6 Cg_endo -98.54 157.63 0.74 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.183 1.922 . . . . 0.0 111.323 153.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.508 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 19.1 p30 -110.36 23.45 14.26 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 -82.73 0.16 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.031 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.85 69.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.594 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.41 71.74 1.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.576 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' N ' HH22 ' A' ' 8' ' ' ARG . . . -84.76 108.19 17.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -109.81 -63.95 1.31 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.809 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.731 -179.044 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.29 125.73 28.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 111.334 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 19.9 m -109.36 140.65 22.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 176.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 5.6 Cg_exo -69.8 103.79 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 111.594 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 12.3 mptt -59.4 150.84 25.25 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -43.1 -48.19 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.295 0.372 . . . . 0.0 111.052 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.863 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.2 p90 -114.47 79.11 1.22 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 167.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.047 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -69.92 -27.06 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.319 0.58 . . . . 0.0 109.945 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 39.4 t80 -168.7 -51.86 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.587 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.0 Cg_endo -104.19 -8.66 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.672 2.248 . . . . 0.0 114.096 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.863 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 44.47 45.91 7.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.416 0.686 . . . . 0.0 111.386 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.67 -82.71 1.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.178 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -94.87 90.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.047 ' HA ' HH22 ' A' ' 8' ' ' ARG . 4.3 mp -69.82 125.47 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.879 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.96 34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.465 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -78.28 -68.83 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.491 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.437 179.808 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.63 144.44 46.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.835 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -74.19 139.49 75.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.039 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.11 70.98 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.541 2.828 . . . . 0.0 113.496 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.19 162.18 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -51.89 133.42 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 4.8 p90 40.32 70.2 0.26 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.066 0.936 . . . . 0.0 111.074 -168.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.766 HH12 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -72.1 -31.25 65.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.046 -172.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.62 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 58.2 t80 -162.19 -43.63 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 19.0 Cg_endo -95.18 -80.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.234 1.956 . . . . 0.0 109.935 159.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 64.0 t30 151.02 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 11' ' ' ASN . . . 50.34 -122.36 12.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.149 168.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.89 88.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.656 0.741 . . . . 0.0 109.845 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.766 ' HA ' HH12 ' A' ' 8' ' ' ARG . 3.4 mp -67.66 133.53 49.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.481 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.28 23.53 14.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.739 0.78 . . . . 0.0 109.214 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 14' ' ' LEU . 25.3 p -116.38 136.8 52.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.819 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.006 177.15 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 61.4 t80 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.79 165.5 25.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.277 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -75.6 154.04 85.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.025 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' HD3' ' A' ' 8' ' ' ARG . 91.8 Cg_exo -46.07 112.83 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.443 2.762 . . . . 0.0 114.041 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.13 113.01 18.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 175.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' HD23 ' A' ' 14' ' ' LEU . 86.3 m 45.29 -90.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.21 -173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -86.05 85.7 7.36 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 176.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' NH2' ' H ' ' A' ' 15' ' ' ALA . 2.9 ptp180 -77.52 -8.29 57.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 56.8 t80 179.68 -58.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.209 169.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 86.3 Cg_endo -105.41 -1.81 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.219 1.946 . . . . 0.0 114.029 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 7.8 p30 56.25 18.61 3.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.854 0.862 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 -71.9 1.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.421 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 8' ' ' ARG . 2.9 p -74.63 100.45 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.512 0.672 . . . . 0.0 109.577 172.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 6' ' ' CYS . 72.9 mt -100.35 131.7 46.13 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.276 0.56 . . . . 0.0 111.525 -174.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' H ' ' NH2' ' A' ' 8' ' ' ARG . . . -147.3 115.58 6.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.66 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 m -138.11 -60.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.222 0.534 . . . . 0.0 109.955 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.869 177.578 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.25 125.78 20.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -78.82 120.04 79.45 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.765 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.55 79.91 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.797 2.331 . . . . 0.0 112.5 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.61 151.89 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.379 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -58.03 137.37 56.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.822 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 4.6 p90 40.77 73.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.268 0.98 . . . . 0.0 110.857 -163.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 14' ' ' LEU . 1.1 ptp180 -70.96 -19.31 62.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.891 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 65.9 t80 -172.29 -54.25 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.468 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 57.9 Cg_endo -99.63 -17.08 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.095 1.863 . . . . 0.0 113.759 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.1 OUTLIER 70.59 0.73 3.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.3 0.64 . . . . 0.0 111.535 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.88 -72.3 0.68 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.344 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -93.46 84.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.709 0.766 . . . . 0.0 109.854 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HA ' ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.6 75.65 7.46 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.37 0.605 . . . . 0.0 111.396 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.17 88.78 7.51 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.3 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.58 19.46 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.501 -178.574 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 55.9 p90 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.82 147.26 46.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.704 0.287 . . . . 0.0 110.912 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 51.0 m -90.03 128.4 49.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.792 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 10.6 Cg_exo -67.98 99.8 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.2 1.933 . . . . 0.0 111.598 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.593 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -84.45 140.95 31.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.255 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -51.62 135.77 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.805 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 1.3 p90 38.29 74.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.08 0.862 . . . . 0.0 111.214 -165.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -18.82 61.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.397 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 7.1 t80 -175.25 -55.2 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.701 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 74.0 Cg_endo -103.4 -1.62 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.633 2.222 . . . . 0.0 114.206 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.9 p-10 41.79 36.22 0.6 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.37 0.668 . . . . 0.0 112.735 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 -53.43 3.98 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.867 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.68 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.69 ' H ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp -82.54 71.09 9.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.166 0.508 . . . . 0.0 110.819 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.39 102.5 14.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 p -161.76 -39.66 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.7 m . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.111 176.342 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.79 164.74 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.359 0.6 . . . . 0.0 111.927 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -152.01 131.32 6.72 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.057 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' ARG . 60.9 Cg_endo -71.43 70.33 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.702 2.268 . . . . 0.0 113.667 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -69.86 159.17 34.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -58.56 138.32 56.88 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.342 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 5.9 p90 41.21 65.23 0.85 Allowed 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 124.093 0.871 . . . . 0.0 111.603 -168.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.817 HH22 ' HA ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -73.91 -21.56 60.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.648 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 62.2 t80 -170.2 -53.94 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.449 173.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 70.0 Cg_endo -99.01 -25.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.777 1.651 . . . . 0.0 114.296 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 8.5 t30 63.94 36.6 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.95 0.881 . . . . 0.0 109.045 -173.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.25 -106.79 0.51 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.602 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.03 95.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.731 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.817 ' HA ' HH22 ' A' ' 8' ' ' ARG . 84.8 mt -83.24 109.49 17.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.993 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.04 32.09 6.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.559 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.83 130.32 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.792 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.463 -0.779 . . . . 0.0 109.84 178.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.71 154.9 18.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -98.04 138.12 20.92 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.729 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 36.5 Cg_endo -66.55 86.33 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.593 2.196 . . . . 0.0 112.082 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.77 155.38 31.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.94 -178.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.9 m -51.64 136.68 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.097 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.826 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 7.3 p90 39.41 68.74 0.34 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.0 -167.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.546 ' H ' ' HE ' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -64.24 -25.79 68.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.854 -174.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.653 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 49.8 t80 -169.39 -52.58 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.668 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 53.4 Cg_endo -108.59 20.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.999 2.466 . . . . 0.0 113.023 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.826 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 8.3 p30 44.04 -105.41 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.818 0.699 . . . . 0.0 110.78 -171.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 11' ' ' ASN . . . 68.23 -107.2 1.97 Allowed Glycine 0 C--N 1.302 -1.313 0 O-C-N 123.571 0.544 . . . . 0.0 112.36 172.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 13' ' ' VAL . 3.4 p -83.18 87.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 7' ' ' PHE . 4.9 mp -81.18 74.55 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.43 89.44 7.4 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.76 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p -140.25 16.15 2.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.465 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 C--O 1.247 0.972 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.9 179.525 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 53.2 p90 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.782 0.325 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.85 -2.51 15.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.456 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.8 m 63.66 141.57 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.737 0.779 . . . . 0.0 112.097 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -83.95 111.16 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.714 2.276 . . . . 0.0 113.191 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 9.7 mptt -79.98 144.38 33.33 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.56 ' O ' HD23 ' A' ' 14' ' ' LEU . 95.4 m -47.33 -56.3 7.12 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.272 0.358 . . . . 0.0 110.615 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.827 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 5.5 p90 -101.84 77.96 1.77 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.653 0.74 . . . . 0.0 109.079 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -60.66 -25.77 66.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.909 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.594 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 14.9 t80 -167.75 -57.45 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.256 168.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 45.4 Cg_endo -104.02 2.74 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.553 2.169 . . . . 0.0 113.432 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.827 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.5 p-10 47.26 28.71 1.07 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.819 0.848 . . . . 0.0 112.165 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.48 -66.36 1.56 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.415 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.5 p -84.18 83.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.012 0.911 . . . . 0.0 109.408 174.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 6' ' ' CYS . 51.9 mt -76.5 81.23 3.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.951 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.11 93.12 4.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.5 p -140.3 7.61 2.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.59 . . . . 0.0 110.067 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.246 0.878 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.131 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 33.1 t80 . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.355 0.597 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.7 135.45 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.03 -0.419 . . . . 0.0 110.983 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p -67.99 140.2 93.49 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.52 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 128.29 17.37 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.701 2.267 . . . . 0.0 113.116 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 1.5 mppt? -96.6 173.55 7.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 58.8 m -43.71 -61.12 1.51 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.557 0.617 . . . . 0.0 110.224 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.923 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 4.9 p90 -92.0 87.91 6.37 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.688 0.756 . . . . 0.0 109.132 167.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.5 ptp180 -71.8 -33.95 68.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.337 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 4.5 t80 -165.76 -51.37 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.738 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 69.6 Cg_endo -101.16 -7.55 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.238 1.959 . . . . 0.0 114.321 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 2.6 p-10 48.26 31.0 2.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.156 0.582 . . . . 0.0 111.541 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.72 -74.85 1.15 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.36 67.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.609 1.195 . . . . 0.0 109.921 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -93.92 151.41 19.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.149 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.66 26.26 5.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p -94.15 -3.71 50.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.014 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.567 -178.767 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.87 128.82 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -81.35 138.78 48.26 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.6 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.03 76.63 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.09 2.527 . . . . 0.0 112.674 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -56.36 148.57 18.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.108 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.96 139.76 57.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.803 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.681 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 13.8 p90 38.54 66.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.663 1.227 . . . . 0.0 110.691 -165.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.701 HH21 HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -55.71 -27.15 48.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.796 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 67.8 t80 -168.06 -53.04 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.84 169.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 97.6 Cg_endo -103.48 -4.25 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.489 2.126 . . . . 0.0 113.895 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.681 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 1.9 p-10 49.84 19.13 0.4 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.795 . . . . 0.0 111.743 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -68.62 1.56 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 8' ' ' ARG . 28.9 m -78.13 142.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 HH21 ' A' ' 8' ' ' ARG . 85.7 mt -136.96 101.82 4.68 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.03 53.78 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.239 0.543 . . . . 0.0 111.072 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -146.69 -167.49 2.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.665 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.638 178.117 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 44.4 p90 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.728 0.299 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.2 86.67 5.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.159 0.504 . . . . 0.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 12.9 m -82.96 128.23 66.34 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.384 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 3' ' ' SER . 3.5 Cg_exo -77.37 103.6 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.971 2.448 . . . . 0.0 111.882 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -84.58 155.58 22.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.864 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -57.4 134.35 55.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.766 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 8.2 p90 42.71 80.92 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.682 1.239 . . . . 0.0 110.986 -161.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HG2' ' HD2' ' A' ' 10' ' ' PRO . 2.3 ptp180 -80.56 -88.82 0.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.559 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.565 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 17.2 t80 -100.29 -44.05 0.22 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 161.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.701 ' HD2' ' HG2' ' A' ' 8' ' ' ARG . 44.1 Cg_endo -104.28 144.85 0.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.787 2.325 . . . . 0.0 111.666 163.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 2.0 t-20 -90.18 13.77 14.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.607 1.194 . . . . 0.0 108.805 171.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.7 -84.12 0.3 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.613 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 94.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 11' ' ' ASN . 69.0 mt -100.7 89.3 3.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.847 -174.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.63 101.19 12.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.7 p -172.91 -27.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.387 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.3 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.197 178.421 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 120.287 0.089 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.73 -141.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.907 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t 72.25 116.68 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 123.591 0.756 . . . . 0.0 110.571 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 152.24 53.83 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.969 2.446 . . . . 0.0 112.969 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -140.68 157.43 45.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.074 178.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.45 139.43 55.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 19.2 p90 43.08 70.41 0.3 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.233 1.016 . . . . 0.0 110.258 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -75.99 -18.19 59.4 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.907 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 11.3 t80 -165.16 -46.07 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.355 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 59.0 Cg_endo -101.06 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.49 2.126 . . . . 0.0 110.882 167.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 19.9 p-10 155.58 4.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.924 1.29 . . . . 0.0 108.09 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' H ' ' H ' ' A' ' 11' ' ' ASN . . . -58.6 -81.46 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.598 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.92 99.59 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.933 0.873 . . . . 0.0 109.919 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 11' ' ' ASN . 34.3 mt -92.3 75.02 5.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 95.76 10.3 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.841 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.7 m -123.14 -38.38 2.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.146 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.246 0.901 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.169 -176.32 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.1 p90 . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.707 0.289 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.31 76.21 3.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.379 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.3 p -93.6 111.49 52.67 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.882 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.53 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 7.4 Cg_exo -71.48 118.0 5.44 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.793 2.328 . . . . 0.0 112.136 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.6 153.56 29.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.682 -176.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.2 m -53.51 133.57 40.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 p90 43.47 75.89 0.09 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.342 1.068 . . . . 0.0 111.291 -162.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.575 HH12 ' H ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -76.29 -21.57 56.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.764 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 2.4 t80 -179.83 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 95.9 Cg_endo -102.82 -16.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.158 1.905 . . . . 0.0 113.255 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 t30 63.18 -149.46 0.34 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -171.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.0 -70.66 3.09 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.716 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -93.55 77.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.757 0.789 . . . . 0.0 109.407 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.01 91.05 6.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.713 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' H ' HH12 ' A' ' 8' ' ' ARG . . . -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.255 0.55 . . . . 0.0 110.141 170.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 p -148.64 29.56 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.153 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.673 -177.449 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.877 0.37 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.49 100.58 10.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.912 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p -79.51 129.29 72.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 24.4 Cg_endo -64.53 96.41 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.856 2.371 . . . . 0.0 112.394 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -81.99 169.97 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.382 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -55.86 135.83 51.79 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 12.7 p90 38.97 67.07 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.591 1.182 . . . . 0.0 110.854 -164.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.575 ' NH1' ' HB2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -57.45 -26.37 61.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.822 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 35.3 t80 -171.9 -55.62 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.37 168.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 56.9 Cg_endo -99.9 -2.81 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.89 1.726 . . . . 0.0 114.397 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 9.3 p30 49.52 29.39 2.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.65 0.78 . . . . 0.0 112.478 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.15 -64.75 1.57 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.818 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.0 p -88.89 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.328 1.061 . . . . 0.0 109.29 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.33 113.77 24.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.447 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.67 -58.43 1.83 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.0 m 67.39 100.92 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.851 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.774 178.733 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 121.019 0.438 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.48 134.33 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.042 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -64.87 141.62 98.4 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 73.6 Cg_endo -75.71 58.21 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.814 2.343 . . . . 0.0 112.408 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.72 153.32 43.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -58.2 150.25 22.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.822 -174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 18.5 p90 39.92 54.46 2.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.046 0.927 . . . . 0.0 110.999 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.516 HH12 ' HB3' ' A' ' 15' ' ' ALA . 3.0 ptp180 -59.9 -27.02 66.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.894 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 10.1 t80 -161.96 -54.36 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.8 167.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 9' ' ' TYR . 83.0 Cg_endo -105.5 -8.32 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.017 1.811 . . . . 0.0 114.179 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 4.2 p30 53.0 15.77 0.63 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.498 0.719 . . . . 0.0 111.966 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.89 -62.66 2.92 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -83.74 137.48 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 169.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.59 158.78 39.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.944 0.402 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -168.94 49.11 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.996 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.5 p -143.06 86.12 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.165 0.507 . . . . 0.0 111.997 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.255 -0.879 . . . . 0.0 109.601 175.223 . . . . . . . . 0 0 . 1 stop_ save_